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SUMMARY 
In this study we aimed at studying the tumor aggressiveness and differentiation potential of 
Ramos Burkitt’s lymphoma cells upon mitogenic stimulation in light of a novel regulator of 
immune cell metabolism and activation, ADPGK. 
We have identified the role of ADPGK in regulation of aerobic glycolysis in Burkitt’s 
Lymphoma cells and shown that its knock-out leads to reduced tumor aggressiveness, as 
measured in-vitro via co-culture, migration experiments and metabolic profile, and in-vivo 
Zebrafish. We found significantly reduced MYC transcription in ADPGK knock-out Burkitt’s 
lymphoma cells and importantly, several folds reduction in accumulated random mutations 
in translocated MYC in these cells. We additionally observed a stalled pathway to 
differentiation of ADPGK knock out B-cells into plasma cells upon stimulation by mitogenic 
signals. Overall, the study provided the first insights into the role of a novel ER resident 
protein acting as a regulator of two complementary phenomenon, cell-differentiation and 
cancer aggressiveness, and thereby opens up new possibilities of therapeutic interventions 
for hematopoietic malignancies.  
 
 
ZUSAMMENFASSUNG 
 
Ziel dieser Studie war es, die Tumoraggressivität und das Differenzierungspotential von Ramos 
Burkitts Lymphomzellen bei der mitogenen Stimulation im Lichte eines neuartigen Regulators 
des Immunzellstoffwechsels und der Aktivierung, ADPGK, zu untersuchen. 
Wir haben die Rolle von ADPGK bei der Regulation der aeroben Glykolyse in Burkitt-Lymphom-
Zellen identifiziert und gezeigt, dass dessen Knock-out zu reduzierter Aggressivität des Tumors 
führt, gemessen in-vitro über Co-Kultur- und Migrationsexperimente, metabolische Profile 
sowie in-vivo in Zebrafischen . Wir fanden eine signifikant reduzierte MYC Transkription in 
ADPGK Knock-Out Burkitt Lymphomzellen und eine verminderte Akkumulation zufälliger 
Mutationen in translozierten MYC in diesen Zellen. Wir beobachteten zusätzlich eine blockierte 
Differenzierung von ADPGK Knockout B-Zellen in Plasmazellen bei Stimulierung durch mitogene 
Signale. Insgesamt lieferte die Studie erste Einblicke in die Rolle eines neuen ER-residenten 
Proteins, das als Regulator zweier komplementärer Phänomene, Zelldifferenzierung und 
Krebsaggressivität agiert, und eröffnet damit neue Möglichkeiten therapeutischer 
Interventionen für hämatopoetische Malignome. 
 
ABBREVIATIONS 
Ab Antibody 
ADP  Adenosine diphosphate  
ADPGK  ADP dependent glucokinase  
ASC Antibody secreting cell 
ATP  Adenosine triphosphate  
BL Burkitt’s lymphoma 
Cas9  CRISPR-associated nuclease 9  
CRISPR  Clustered Regularly Interspaced Short 
Palindromic Repeats  
CSR Class switch recombination 
ER  Endoplasmic reticulum  
FDG Fluorodeoxyglucose 
G6PD  Glucose-6-phsophate dehydrogenase  
Gata1  GATA Binding Protein 1  
GC Germinal centre 
GFAT  Glutamine:fructose-6-phosphate 
amidotransferase  
GFP  Green fluorescence  
HK  Hexokinase  
Hpf  Hour post fertilization  
Ig Immunoglobulin 
IP3R Inositol triphosphate receptor 
IRE Inositol requiring enzyme 
KO  Knockout  
LDH  Lactate dehydrogenase  
MYC  Myelocytomatosis oncogene  
NADH  Nicotinamide adenine dinucleotide  
NADPH  Nicotinamide adenine dinucleotide 
phosphate  
NBDG 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-
yl)Amino)-2-Deoxyglucose glucose 
OXPHOS  Oxidative phosphorylation  
PAM  Protospacer adjacent motif  
PMA  Phorbol 12-myristate 13-acetate  
PPP  Pentose phosphate pathway  
PYR  Pyruvate  
ROS  Reactive oxygen species  
SHM Somatic hypermutation 
TAM Tumor associated macrophage 
TCA cycle  Tricarboxylic acid cycle  
VDJ Variable diversity joining segment 
WT  Wild type  
XBP X-box binding protein 
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INTRODUCTION 
Warburg Effect or aerobic glycolysis 
Normal somatic cells have a strict control of cell cycle and metabolism and possess 
numerous checkpoints to regulate the growth and differentiation status of the cell during its 
life cycle. However, through rare events, cells can acquire traits which leads them to a fully 
transformed cancerous state which is marked by uncontrolled growth and proliferation 
(Fouad & Aanei, 2017). The most common of these traits found in cancer is a metabolic 
state enabling the cells to upregulate glucose uptake and utilization several folds even in the 
presence of oxygen. The process, termed as Warburg effect or aerobic glycolysis, provides 
an evolutionary growth advantage to cancer cells and has in recent years become 
increasingly important as a target for curbing aggressively growing malignancies (Cairns, 
Harris, & Mak, 2011; DeBerardinis, Lum, Hatzivassiliou, & Thompson, 2008; Gatenby & 
Gillies, 2004; Liberti & Locasale, 2016). Glycolysis, or lytic metabolism of glucose, involves 
the conversion of glucose to pyruvate with production of ATP. Pyruvate is further converted 
into lactic acid as a waste product. In the presence of oxygen, glycolysis is redirected at the 
step of pyruvate, which is oxidised into CO2 and H20 by mitochondrial oxidative 
phosphorylation. This process of reduced lactate production by inhibition of the cycle at 
pyruvate in presence of oxygen is termed as ‘Pasteur effect’. Under anaerobic conditions, 
such as in muscle cells during bursts of short intense exercise, enough oxygen is not present 
for oxidation of pyruvate and NADH produced in glycolysis. In such cases, NAD+ is 
reobtained from NADH by reduction of pyruvate to lactate, using the enzyme lactate 
dehydrogenase (Proia, Di Liegro, Schiera, Fricano, & Di Liegro, 2016). Thus, different fates of 
glucose over range of oxygen concentrations help the cells in adapting to the 
microenvironmental conditions prevalent at that time and continue the process of energy 
generation, although with varying efficiencies (Phan, Yeung, & Lee, 2014). In addition to 
these common occurrences, there arises a condition, mostly observed in fast proliferating 
cells or cancer, where glucose is converted to lactic acid even in the presence of sufficient 
amounts of oxygen. Known as aerobic glycolysis or Warburg effect, it is known to provide a 
growth advantage to tumors with respect to their microenvironment and additionally aides 
in selection of resistant and malignant cells in the developing tumor (Gatenby & Gillies, 
2004; Liberti & Locasale, 2016).  
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Figure 1.1 : Delivery of glucose and oxygen to tissues in the body, entering the cells via 
specific glucose transporters. The glucose taken up is primed into Glucose-6 phosphate by 
hexokinases to prevent its exit from the cell, and further through glycolysis converted to 
pyruvate with generation of 2 ATP molecules per glucose. In the presence of oxygen, 
mitochondrial oxidative phosphorylation oxidises pyruvate to HCO3, and generates 36 
additional ATP molecules per glucose. In anoxic conditions, pyruvate is reduced to lactic 
acid, which is then exported from the cell as a waste product. Hydrogen ions (H+) are 
produced by both the processes and causes acidification of the extracellular space. HbO2 
represents oxygenated haemoglobin. Image adapted from (Gatenby & Gillies, 2004). 
 
The importance of glucose metabolism for cancer cells was diminished shortly after the 
discovery of Warburg effect but has recently gained significance in the past decade, due to 
the widely known clinical imaging technique positron-emission tomography (PET) (Gatenby 
& Gillies, 2004). PET employs tracer molecule 18fluorodeoxyglucose (FdG) as a glucose 
analogue and has proven with majority of lesions the increased glucose uptake and 
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accumulation of the tracer compared to non-malignant tissues in the body (Cox, Mackie, & 
Eliceiri, 2015). Another piece of information conveyed by PET scans is the avid trapping of 
fluorescent-glucose by immune cells owing to their increased proliferative phenotype and 
thereby upregulated glycolysis under inflammatory conditions (Escuin-Ordinas et al., 2013). 
Nonetheless, there exists a major difference between immune cell metabolism and cancer, 
in that the aerobic glycolytic phenotype is only transiently expressed in the former whereas 
it is stably and epigenetically switched on in case of the latter. Owing to this phenotypic 
switching to aerobic glycolysis, immune cells serve as an effective tool for modelling cancer 
cell metabolism. 
Burkitt’s lymphoma 
Burkitt’s lymphoma (BL), a malignancy of germinal centre B-cells, is the fastest growing 
human cancer (Molyneux et al., 2012) and owing its growth to one of the most widely 
studied oncogenes and regulator of glycolysis, MYC, provides a perfect model for study of 
Warburg effect (Buttgereit, Burmester, & Brand, 2000; Schmitz, Ceribelli, Pittaluga, Wright, 
& Staudt, 2014). The cancer, a non-Hodgkin’s type Lymphoma, is one of the most commonly 
found paediatric cancer in regions of Africa and South America (Molyneux et al., 2012). The 
tumor is characterized by a very high proliferation rate with mostly monomorphic, medium-
sized cells. The cells express markers typical of germinal-centre B-cells such as CD20, IgM, 
CD19, PAX5, CD10 and BCL6, but do not express nuclear TdT, CD5 and BCL2 (Dozzo et al., 
2017). Under the microscope, upon H&E staining of tumor biopsies, a typical starry sky 
appearance is appreciated due to the presence of tangible-body macrophages (Andrade-
Filho, 2014). The dense involvement of macrophages in almost all cases of Burkitt’s 
lymphoma provides an additional advantage of studying tumor-microenvironment 
interrelationship (Scott & Gascoyne, 2014).  
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Figure 1.2: Dense involvement of tumor microenvironment in Burkitt’s lymphoma with upto 
10% of cells in the tumor occurring as immune cells (macrophages). Macrophages are 
depicted in red and in purple are the tumor cells with a large prominent nucleus and 
minimal cytoplasm.  
 
The translocation t(8;14)(q24;q32) is the characteristic genetic hallmark of Burkitt’s 
lymphoma, identified in most of the patient biopsies (Bemark & Neuberger, 2000; Cowling, 
Turner, & Cole, 2014; Eick & Bornkamm, 1989; Xu-Monette et al., 2016). This translocation 
brings MYC proto-oncogene into proximity with the immunoglobulin locus (H/L chain). 
Owing to the influence of heavy transcriptional activity of this locus, MYC expression is 
dysregulated and leads to a constitutive overexpression of MYC in Burkitt’s lymphoma 
(Bemark & Neuberger, 2000). The overexpression of this proto-oncogene affects its 
downstream target genes, i.e. almost 15 percent of all genes; involved in cell proliferation, 
growth, differentiation, apoptosis and stem-cell renewal (Cowling et al., 2014). However, 
along with MYC translocation and overexpression, there are several other factors 
responsible for driving lymphomagenesis. Targeting MYC expression, nonetheless, remains 
as an attractive strategy to curbing haematological malignancies and its expression used as a 
prognostic marker. 
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Figure 1.3: Diagrammatic representation of MYC translocation (t(8;14)(q24;q32)) in Burkitt’s 
lymphoma placing c-MYC under the locus of heavy chain immunoglobulin promoter. 
 
Somatic hypermutation and translocated MYC mutations 
The genetic information leading to production of the vast repertoire of structural and 
functional diversity in antibodies was a mystery for long time in immunology. The discovery 
of the basic four-chain structure of antibodies established a huge amount of heterogeneity 
in amino-terminal domains of polypeptide chains and was probably the first clue towards an 
inlying genetic mechanism responsible for introducing somatic diversification in antibodies 
(Li, Woo, Iglesias-Ussel, Ronai, & Scharff, 2004). A limited number of genetic elements are 
responsible for generation of antibody diversity through a process called Somatic 
hypermutation (SHM). Somatic hypermutation is the process of modification of a germline 
immunoglobulin genetic sequence by introduction of nucleotide editions, mainly in the form 
of point mutations, in the locality around the rearranged variable immunoglobulin (Ig V) 
domain (Clark, Ganesan, Papp, & van Vlijmen, 2006; Mao et al., 2004; Peled et al., 2008).  
Somatic hypermutation takes place in humans after V-D-J recombination and is found to 
occur during different phases of the immune response. Genetic rearrangement takes place 
during B-cell development and is required to generate a primary pool of antibodies for 
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targeting foreign antigens (Peled et al., 2008). This is usually provided via IgM antibodies 
exhibiting low binding affinity to the antigen, however the binding is often enough to trigger 
a physiological response against the antigen (Li et al., 2004). Upon binding of antigens to B-
cells and their recognition by specific receptors, B-cells undergo rapid proliferation and form 
discrete structures within immunological areas in the body; called Germinal centres (GC). It 
is within these GCs that somatic hypermutation takes place and an alternative repetition of 
SHM and antibody binding mediated selection leads to affinity maturation of antibodies 
(Wagner & Neuberger, 1996). Thereafter, in surplus to the introduction of point mutations 
in the IgV region via SHM, Class-switch-recombination (CSR) takes place in the IgH 
(immunoglobulin heavy) locus. CSR involves recombination based deletion of regions of IgH 
locus, removing the exons of IgM constant region and thereby brings the segments 
surrounding the deleted portions (such as VDJ and IgC (immunoglobulin constant) regions) 
together, to form a functional antibody gene but of a different isotype. Thus, whereas SHM 
serves to increase the heterogeneity and repertoire of antibody variable region, CSR serves 
to increase the interaction options of antibodies with same variable region to different 
effector molecules (Di Noia & Neuberger, 2007; Peled et al., 2008; Wagner & Neuberger, 
1996).  
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Figure 1.4: a: Schematic illustration of the process of Somatic hypermutation (SHM) and 
class-switch-recombination (CSR). SHM introduces point mutations in VDJ region (indicated 
by *), resulting in affinity maturation while CSR between switch (S) regions in the antibody 
leads to isotype switching. Different constant regions are denoted by C. b: Antibody 
assembly, showing the Heavy chains (HC), Light chains (LC), constant and variable regions 
and the VDJ domain located in the HC region (on both arms). 
 
The process of SHM and CSR is performed through targeted deamination of deoxycytidine 
residues, which converts them to deoxyuridine and subsequently the C:G nucleotide pairs 
are transformed into U:G mismatches. This deamination of deoxycytidine to deoxyuridine is 
catalysed by an enzyme called Activation induced cytidine deaminase (AID). The enzyme is 
expressed specifically in B-cells and acts only on single stranded DNA templates, 
(Bransteitter, Pham, Scharff, & Goodman, 2003; Duquette, Pham, Goodman, & Maizels, 
2005) thus highlighting its role upon increased transcriptional activity of the locus. Overall, 
a 
b 
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the enzyme is likely to introduce increasing number of mutations in a highly proliferating 
(transcriptionally active cell), such as B-cells activated by antigen. 
Post discovery of translocated MYC allele in Burkitt’s lymphoma, it was noted that the allele 
in most of the Burkitt’s lymphoma lines had acquired several mutations and most of the 
observed mutations were conserved across tumor biopsy samples (Bemark & Neuberger, 
2000; Mao et al., 2004; Vincent et al., 2009). Translocation of MYC into the immunoglobulin 
locus transforms the MYC into becoming a target for antibody hypermutation associated 
with the locus. The process has been observed in-vitro as well, such as for the Burkitt’s 
lymphoma cell line Ramos (Bemark & Neuberger, 2000). Ramos cells in culture under 
standard lab conditions have been found to accumulate mutations at a high rate in its 
translocated MYC allele (Bemark & Neuberger, 2000). The process is constitutive for the cell 
line and the accumulation of mutations increases with the length of culturing of these cells. 
Thus, the cell line provides a perfect model to assess mutability and expression status of 
translocated MYC under various external conditions such as metabolic state of the cell. The 
mutability and expression of MYC could consequently be analysed with respect to changes 
in tumor aggressiveness of this cell line in in-vitro conditions.  
B-cell differentiation 
B-cell differentiation can be split into two phase, early and terminal B-cell differentiation. 
Early phase of B-cell differentiation is a tightly scrutinized process which occurs in liver of 
the developing foetus or in the bone marrow (BM) of adults, from common lymphoid 
progenitor cells (Roth et al., 2014; Zhang, Garcia-Ibanez, & Toellner, 2016). Commitment to 
B-cell lineage is dependent on a multitude of transcription factors such as early B-cell factor 
(COE1, encoded by EBF1), PU.1 (encoded by SPI1), E2A (encoded by TCF3) and paired box 
protein 5(PAX5) (Pieper, Grimbacher, & Eibel, 2013). Positive selection post rearrangement 
of IgH and IgL genes leads to a population of pre (precursor)-B cells. These cells express 
transmembrane form of the heavy chain µ, known as µM, which is an important checkpoint 
in the pre-B-cell receptor for B-cell development. Entry through this checkpoint allows for 
IgL gene segment rearrangement and clonal expansion. Second checkpoint is the presence 
of surface IgM where through negative selection, tolerance mechanisms act on autoreactive 
clones by deleting, anergizing or editing them. Cells surviving the negative selection, the 
immature B-cells, leave the bone marrow and migrate to secondary lymphoid organs such 
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as spleen where they continue their development. In the spleen, cells pass through 
transitional stages T1 and T2, and undergo further negative selection to become mature B-
cells. Transitional B-cells can additionally be homed to splenic marginal zone (MZ) where 
they remain as non-circulating MZ B-cells, or like in case of most of the transitional cells, 
they could mature into naïve follicular B-cells, which circulate freely follicles, lymph nodes 
and BM until their death or undergo further differentiation upon antigen encounter (Pieper 
et al., 2013; Zhang et al., 2016).  
The next phase of B-cell differentiation typically involves encounter with antigen and the 
response type depends on the type of antigen. Fully differentiated plasma cell (short-lived 
or long-lived) can thus develop from MZ B-cells, follicular cells, Germinal centre (GC) B-cells 
and from memory cells. Germinal centre cells are derived from follicular B-cells when the 
latter encounter an antigen and at the same time receive help from T-cells (T-cell dependent 
activation (TD)). There exists another pathway of activation via T-cell independent activation 
(TDI), known to occur in response to certain lipopolysaccharides and phorbol esters. The TDI 
is preferentially followed by a subset of B-cells called the B1 cells and are responsible for 
providing first line of defence by producing natural IgM. B-cells undergo extensive 
proliferation along with affinity maturation and CSR in germinal centres, which are 
specialized follicular areas for differentiation of GC B-cells. GC based response peaks 
between day 10 and 14 after encounter of antigen and then diminishes. The response gives 
rise to Plasma cells and Memory cells. Plasma cells are terminally differentiated antibody 
secreting cells (ASCs) and memory cells have the capability to differentiate into PCs if 
provided appropriate signals. However, the differentiation from GC cells to plasma cells 
involves several intermediate stages. Activated GC B-cells (T-cell dependent/independent 
(TD/TDI) stimulation) undergo a high proliferative phase characterized by Warburg like 
upregulation of metabolism and growth, and subsequent differentiation to plasma/memory 
cells (Brand, Leibold, Luppa, Schoerner, & Schulz, 1986; DeFranco, Raveche, & Paul, 1985; 
Garcia-Manteiga et al., 2011; Semmel et al., 1988; Shapiro-Shelef & Calame, 2005). These 
stages of proliferation and differentiation also thereby furnish ideal scenarios to analyse the 
regulation of metabolic activity of a fast-growing cancer under activated and quiescent 
states.  
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Figure 1.5: B-cell differentiation from B1 cells: On encounter with foreign antigens, marginal 
zone, follicular zone cells can differentiate into short-lived plasma cells. Activated follicular 
cells can form a germinal centre from which Plasma cells can either form directly or through 
a memory B-cell stage. Plasma cells resulting from germinal centres can become long-lived if 
they detect suitable survival niches in the bone marrow. (CSR: class-switch recombination). 
Image adapted from (Shapiro-Shelef & Calame, 2005) 
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Several transcription factors are necessary to drive the irreversible process of differentiation 
of GC B-cells to plasma cells. BLIMP1, the most widely studied transcription factor, is 
sufficient under appropriate conditions and at appropriate developmental stage of B-cells to 
induce differentiation into plasma cells (Ding, Bi, Chen, Yu, & Ye, 2013). It is expressed 
mainly by bone marrow and splenic plasma cells and is required for terminal differentiation 
and immunoglobulin secretion. It leads to termination of cell cycle (by repression of 
proliferative genes such as MYC), repression of genes characteristic of mature and GC B-cells 
and the induction of immunoglobulin secretion. It also represses expression of two 
important GC transcription factors, BCL-6 and PAX5. PAX5 repression is an important event 
in differentiation, leading to derepression of XBP1 (X-box binding protein 1), which is one of 
the first transcription factors shown to be necessary for plasmacytic differentiation. XBP1 is 
a primary regulator of immunoglobulin secretion in plasma cells. Along with these, IRF4 is 
another transcription factor known to be involved in early plasma cell development, being 
required in the activated B-cells for the proliferative phase (Bertolotti et al., 2010; Garcia-
Manteiga et al., 2011; Jourdan et al., 2011; Reimold et al., 2001; Shaffer et al., 2002; Todd et 
al., 2009; Zhang et al., 2016). A list of important B-cell differentiation markers and 
transcription factors, and their expression status at different stages of differentiation is 
provided in Table 1. 
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 Pre-B Imm-B cell Trans-B cell MZ FL-B cell Act 
B cell 
GC-B cell Memory 
B cell 
PC 
long 
lived 
Immunoglobulin IgM
-
 IgM
+
, IgD
-
 IgM
high
, 
IgD
low
 
IgM
+
, 
IgD
low
 
IgM
low
, IgD
+
 IgM
+
, IgD
+
 IgM/G/A/E
+
, 
IgD
var
 
IgM/G/A/E
+
, 
IgD
-
 
Ig
-
 
Positive markers CD10, CD19, 
CD20, CD24, 
CD38, 
IL7/4/3R 
CD10, CD19, 
CD20, CD21, 
CD24
high
, 
CD38
high
, 
CD40, CD268, 
IL4R 
CD5, CD19, 
CD20, CD21, 
CD24
high
, 
CD38
high
, 
CD268, CCR7 
CD1c, 
CD19, 
CD20, 
CD21
high
, 
CD27
low
 
CD19, CD20, 
CD21, CD22, 
CD23, CD24, 
CD268, CCR7, 
CXCR5 
CD19, CD20, 
CD25, CD27, 
CD30, CD69, 
CD80, CD86, 
CD95, CD135, 
CD268, CXCR5 
CD10, CD19, 
CD20, CD23, 
CD27, 
CD38
high
, 
CD95, CD135, 
CD268, CXCR5 
CD19, CD20, 
CD27
var
, CD40, 
CD268, CCR7, 
CXCR4, 5, 7 
CD27, CD28, 
CD38
high
, 
CD138, 
CD268, 
CD269, 
CXCR4 
Enzymes RAG-1,2 
EZH2
low
 
     AID 
EZH2 
  
Transcription 
factors 
         
 
Table 1: Markers for B-cell development. Imm: Immature, Trans: Transitional, MZ: Marginal zone, FL: Follicular zone, Act: Activated, GC: Germinal centre, 
PC: Plasma cell.   
 
Ikaros, Aiolos 
Pax5 
EBF1, E2A 
IRF4 
BCL6 
Pax5 BLIMP1 
IRF4 
XBP-1S 
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ADP dependent glucokinase 
ADP-dependent glucokinase (UniProtKB-Q9BRR6) uses ADP to convert a molecule of glucose 
to glucose-6-phosphate. Human ADPGK is located at chromosome 15 (15q24.1) and is 
localized in the lumen of rough ER. Initially identified in Archaea, it was shown to be 
important in glucose breakdown with a modified Embeden-Meyerhof-Parnas pathway 
(EMP), typical for Archaea (Kengen et al., 1994).  Human ADPGK has been shown to be highly 
specific for utilization of ADP, unlike the Archael ADPGK, which can employ other nucleotide 
diphosphates too as the phophoryl donor (M. M. Kaminski et al., 2012; J. P. Richter, Goroncy, 
Ronimus, & Sutherland-Smith, 2016; S. Richter et al., 2012). ADPGK has a very high 
specificity for glucose as a substrate and does not show any activity with other 
carbohydrates or even with 2-deoxyglucose. Despite the similarity in function to hexokinases 
in priming of glucose, it shows significant differences in enzyme kinetics. Whereas 
hexokinases (I to IV) are inhibited by their product, glucose-6-phosphate, ADPGK is inhibited 
by high concentrations of glucose and AMP. Also, ADPGK has an optimal temperature for its 
enzyme activity at 42oC and a bimodal optimum pH at around 5.75 to 6.5 and 8.75 to 9 (M. 
M. Kaminski et al., 2012).  
ADPGK is known to be a master regulator of Warburg effect and has been shown to play a 
role in T-cell activation and induction of glycolytic phenotype by our lab in previous studies 
(M. M. Kaminski et al., 2012). Seated in the lumen of rough-ER (Endoplasmic Reticulum), 
serving as a glucose sensor and regulating protein glycosylation, the protein is also 
hypothesized to play an important role in activation-based differentiation of B-cells which 
are highly dependent on ER biogenesis and extensive protein shuttling upon activation by 
mitogenic signals. Use of ADP instead of ATP by ADPGK for priming glucose hints at its role in 
nutrient deprived and hypoxic conditions, such as those prevalent in tumor growth, where 
ATP is available in lean amounts (M. M. Kaminski et al., 2012; J. P. Richter et al., 2016; S. 
Richter et al., 2012). Thus, knowing the importance of this protein in immune cell 
metabolism and cancer, it will be interesting to find out the effect bestowed upon Burkitt’s 
lymphoma cells such as Ramos (ATCC CRL-1596) by ADPGK with respect to their oncogenic, 
differentiation potential.  
 
 
INTRODUCTION 
14 
 
Tumor microenvironment 
The term tumor microenvironment implies to the presence of non-malignant cells and 
tissues present in the tumor and its immediate vicinity. These cells could be immune cells, 
fibroblasts and cells/tissues comprising the vasculature. The context is also used to refer to 
the proteins secreted by the cells existing in the tumor, which support the growth of tumor 
cells (Scott & Gascoyne, 2014).  
For B-cell lymphomas, the microenvironment is highly infiltrated with variety of immune 
cells, stroma, ECM (extracellular matrix) and blood vessels. However, the degree of 
involvement of these components with the cancer cells depends on the genetic profile 
(aberrations) of the cancer cells, as it decides the extent to which these cancer cells depend 
on presence of external factors for survival and growth and not to forget, the inflammatory 
response by the host (Burger & Peled, 2009; Scott & Gascoyne, 2014). A cumulative effect of 
all these factors dictates the wide variations found in tumor microenvironments between 
different lymphoma subtypes. 
Burkitt’s lymphoma, characterized by a strong regulation from translocated, overexpressed 
MYC, has an autonomous survival instinct, which implies that actions are planned by the cell 
and depend much lesser on various microenvironmental constituents compared to other 
lymphomas. The only microenvironment observed in case of Burkitt’s lymphoma is the 
presence of large number of tangible-body macrophages (Scott & Gascoyne, 2014; M. L. Xu 
& Fedoriw, 2016). These macrophages are known to decide the fate of tumor aggressiveness 
by transforming into tumor-promoting (M2) or tumor-killing (M1) phenotypes (Galvan-Pena 
& O'Neill, 2014; Gensel, Kopper, Zhang, Orr, & Bailey, 2017), and thus become exceedingly 
important in research based on targeting Burkitt’s lymphoma. 
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Figure 1.6: Figure shows the microenvironmental differences between three lymphoma 
subtypes. Microenvironmental constituent content ranges from 99% in Hodgkin’s lymphoma 
to about 10% in Burkitt’s lymphoma. FOXP3, forkhead box protein P3; MCL, mantle cell 
lymphoma; DLBCL, diffuse large B cell lymphoma; TH, T helper; MALT, mucosa-associated 
lymphoid tissue; TFH, follicular T helper; TFR, follicular regulatory T;HRS, Hodgkin Reed–
Sternberg. Image adapted from (Scott & Gascoyne, 2014). 
 
 
 
 
 
INTRODUCTION 
16 
 
Macrophage polarization 
Macrophages form an indispensable part of the innate immune system owing to their 
antigen-presenting and phagocytic capabilities. They possess the capability to respond to 
various signals from foreign antigens in the body and perform phagocytosis and killing of 
bacteria and other harmful organisms. They are also known to present antigens to T-cells 
and initiate the process of inflammation by release of cytokines. Macrophages are basically 
the differentiated form of blood monocytes, and depending on the type of antigen 
encountered and the signals received, they present a great amount of heterogeneity in 
morphology, cytokines released and the effect induced (Szulzewsky et al., 2015). They 
likewise respond to signals produced by different tumors and can be polarized (activated) 
into pro-inflammatory (known as M1 or classical type) or anti-inflammatory (known as M2 or 
alternative type) macrophages. M1 polarized macrophages are responsible for Th1 cell 
response, killing of pathogens and type I inflammation, whereas M2 macrophages induce 
tissue growth and wound healing besides inducing cessation of inflammation (Colegio et al., 
2014; Galvan-Pena & O'Neill, 2014; Subei & Cohen, 2015; Szulzewsky et al., 2015).  
Aggressively growing tumors are known to employ myeloid-derived macrophages as tumor-
promoting agents in the microenvironment (Colegio et al., 2014). A massive accumulation of 
these drivers of tumor growth and immune suppressors is often found in the advanced 
growth stages of cancerous lesions. These macrophages are termed as tumor-associated 
macrophages (TAMs) and are shown to be of important prognostic value, with some cancers 
showing regressions by the presence of TAMs while most others linked to a poor prognosis 
(Szulzewsky et al., 2015). In regressing tumors, most of the TAMs are detected to be of M1-
subtype whereas malignant, aggressively growing tumors have an overwhelming presence of 
M2-TAMs (Allavena, Sica, Solinas, Porta, & Mantovani, 2008; Mantovani, Sozzani, Locati, 
Allavena, & Sica, 2002; Murdoch, Muthana, Coffelt, & Lewis, 2008).   
M2 macrophages have a reduced antigen-presenting capability, suppress immune response 
mediated by T-cells by limiting their proliferation, and promote angiogenesis, to name a few 
factors by which they promote the growth of the associated tumor (Mantovani et al., 2002). 
Observed phenotypic differences between M1 and M2 macrophages can also be linked to 
their underlying metabolic differences, where M1 macrophages are characterized by a high 
glycolytic profile, increased glutamine uptake and anaplerosis, and high NO (nitric oxide) and 
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ROS generation for clearance of foreign cells (Fig. 1.7) (Galvan-Pena & O'Neill, 2014; 
Ghesquiere, Wong, Kuchnio, & Carmeliet, 2014). M2 macrophages on the other hand rely on 
oxidative phosphorylation for energy generation, use glutamine for synthesis of polyamines 
and generate proline and citrulline which promote tissue growth. 
 
Figure 1.7: Metabolic profile of M1 and M2 macrophages. a M1 macrophages are 
characterized by: 1) High glycolytic rate (blue), 2) Increased pentose phosphate pathway 
(PPP) (purple) to generate NADPH for maintaining redox homeostasis and generating ROS 
(reactive oxygen species) via NADPH oxidase. ROS is additionally generated from 
mitochondria. 3) Basal rate of fatty acid oxidation (FAO) (red), 4) Glutamine uptake to fuel 
the TCA cycle anaplerotically (green), 5) Arginine is metabolized by iNOS (inducible nitric 
oxide synthase) to generate NO (nitric oxide) (tan) b M2 macrophages display: 1) Increased 
FAO to fuel energy demands (red), 2) Reduced glycolysis due to expression of PFKFB1 (grey), 
3) Reduced PPP by CARL (carbohydrate kinase-like protein), 4) Arginine metabolism by 
arginase-1 to generate proline and citrulline. Image adapted from (Ghesquiere et al., 2014). 
 
Zebrafish as xenograft model 
Zebrafish (Danio rerio) belongs to the family Cyprinidae and are native of Indian rivers with 
distribution across South-Asia. Zebrafish models are being extensively used in biomedical 
research for studying developmental biology, neuroscience, oncology and metabolism to 
name a few (Bradbury, 2004). They have a life span of 4-5 years and retain sexual activity 
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throughout their lifetime, with a single female capable of giving hundreds of eggs in a week, 
making the organism very useful for high-throughput studies (Kalueff, Stewart, & Gerlai, 
2014; Spence, Gerlach, Lawrence, & Smith, 2008). The zebrafish embryos undergo primary 
development within 48 hours and with lack of an adaptive immune system until 4 weeks 
post fertilization, the larvae serve as a perfect model to study growth of cancer xenografts 
(Barriuso, Nagaraju, & Hurlstone, 2015; van der Ent et al., 2014). 
The model serves as a much more sophisticated alternative for tumor growth compared to 
2D culture arrays or matrix systems and at the same time providing a natural dynamic 
environment to the xenografted cells. Cancer cells injected in zebrafish larvae provide rapid 
growth analysis with much wider and feasible imaging possibilities compared to other lab 
animals owing to the transparent nature of larvae in initial days of growth. The fishes can 
also be induced to be non-pigmented in later stages of growth using chemicals such as PTU 
(1-phenyl 2-thiourea) or employing casper pigmentation mutant strains (Antinucci & 
Hindges, 2016). Transgenic zebrafish lines such as kdrl:GFP or mpeg1:mcherry enable 
fluorescent labelling of vasculature and immune cells (macrophages) respectively and serve 
as excellent options for studying tumor microenvironment (Ellett, Pase, Hayman, 
Andrianopoulos, & Lieschke, 2011; Ibrahim & Richardson, 2017). 
Though the optimum growth temperature of zebrafish is 28oC, the fishes can be maintained 
at temperatures upto 34oC to provide an optimum growth temperature to xenografted 
mammalian cells, without apparent negative effects to zebrafish larvae.  
 
Aims 
Activation induced proliferation and differentiation of B-cells furnishes ideal scenarios to 
analyse the regulation of metabolic activity of a fast-growing cancer under activated and 
quiescent states. Employing Burkitt’s lymphoma derived Ramos BL (Burkitt’s lymphoma) cells 
for this study, we will try to decipher the metabolic phenotype of these cells and their 
potential to differentiate in the light of ADPGK (ADP dependent glucokinase), which is known 
to be highly expressed in immune cells and cancer and has been shown to play a role in 
activation of T-cells.  
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Correspondingly, we hypothesize in this study that knock-out of ADPGK from Ramos BL cells 
will induce a metabolic catastrophe upon these cells, which will affect the tumor 
aggressiveness of these cells in-vitro and in-vivo zebrafish. The knock-out is also proposed to 
stall the activation mediated differentiation of these cells and thereby providing a novel 
regulator of two mutually complementary pathways, malignancy and differentiation. 
We aim to achieve this by several investigations such as: 
1. To study the differentiation status of Ramos BL cells and their ADPGK knock-out 
counterparts upon activation.  
2. Overviews of metabolic changes such as glycolytic enzyme expression, kinetics, 
amino-acid and glucose uptake in ADPGK knock-out cells.  
3. Study of the expression and mutational status of translocated MYC (t(8;14)(q24;q32)) 
in ADPGK knock-out and wild type cells. 
4. Effect of ADPGK knock-out on tumor-microenvironment (tumor associated 
macrophages (TAMs)) in-vitro. 
5. Finally, for in-vivo characterization of tumor developing capability of ADPGK knock-
out cells, we will study the growth of Ramos BL xenografts in zebrafish. 
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MATERIALS 
Chemicals  
Name  
 
Company  
2-mercaptoethanol  Merck, Darmstadt, Germany  
2-propanol  Carl Roth, Karlsruhe, Germany  
6-aminocaproic acid  Sigma-Aldrich, St. Louis, U.S.A.  
Acetic acid  Carl Roth, Karlsruhe, Germany  
Acetone  Sigma-Aldrich, St. Louis, U.S.A.  
Agarose  Carl Roth, Karlsruhe, Germany  
Amino persulfate (APS)  Sigma-Aldrich, St. Louis, U.S.A.  
Ammonium bicarbonate  Sigma-Aldrich, St. Louis, U.S.A.  
Ampicilin  PanReac AppliChem, Darmstadt, Germany  
Bacteriological agar  Sigma-Aldrich, St. Louis, U.S.A.  
Bovine serum albumin (BSA)  Santa Cruz Biotechnology, Dallas, U.S.A.  
Bromophenoblue  Merck, Darmstadt, Germany  
Calcium chloride (CaCl)  Sigma-Aldrich, St. Louis, U.S.A.  
Citric acid monohydrate  Carl Roth, Karlsruhe, Germany  
Diethyl pyrocarbonate (DEPC)  Sigma-Aldrich, St. Louis, U.S.A.  
Dipotassium phosphate (K2HPO4)  Sigma-Aldrich, St. Louis, U.S.A.  
Dithiothreitol (DTT)  Merck, Darmstadt, Germany  
Ethanol  Carl Roth, Karlsruhe, Germany  
Ethylenediaminetetraacetic acid disodium salt 
dihydrate (EDTA)  
Carl Roth, Karlsruhe, Germany  
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Formaldehyde  Sigma-Aldrich, St. Louis, U.S.A.  
Formamide  Sigma-Aldrich, St. Louis, U.S.A.  
Fructose-1,6-bisphosphate (FBP)  Sigma-Aldrich, St. Louis, U.S.A.  
Glucose-6-phosphate (G6P)  Sigma-Aldrich, St. Louis, U.S.A.  
Glyceraldehyde-3-phosphate (GAP)  Sigma-Aldrich, St. Louis, U.S.A.  
Glycerol  Sigma-Aldrich, St. Louis, U.S.A.  
Glycine  Sigma-Aldrich, St. Louis, U.S.A.  
Perchloric acid (HClO4)  Sigma-Aldrich, St. Louis, U.S.A.  
Hydrogen chloride  Sigma-Aldrich, St. Louis, U.S.A.  
Lithium chloride (LiCl)  Applichem, Darmstadt , Germany  
Magnesium chloride 6-hydrate (MgCl)  PanReac AppliChem, Gatersleben, Germany  
Methanol  Carl Roth, Karlsruhe, Germany  
Milk powder  Carl Roth, Karlsruhe, Germany  
Monopotassium phosphate (KH2PO4)  Sigma-Aldrich, St. Louis, U.S.A.  
N,N,N′,N′-Tetramethylethylenediamine 
(TEMED)  
Sigma-Aldrich, St. Louis, U.S.A.  
Nicotinamide adenine dinucleotide (NADH)  Sigma-Aldrich, St. Louis, U.S.A.  
Paraformaldehyde (PFA)  Merck, Darmstadt, Germany  
Phosphoenolpyruvate (PEP)  Sigma-Aldrich, St. Louis, U.S.A.  
Potassium bicarbonate (KHCO3)  Sigma-Aldrich, St. Louis, U.S.A.  
Potassium chloride (KCl)  Carl Roth, Karlsruhe, Germany  
Potassium hydroxide (KOH)  Sigma-Aldrich, St. Louis, U.S.A.  
Potassium phosphate (K3PO4)  Sigma-Aldrich, St. Louis, U.S.A.  
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Proteinase inhibitor  Roche, Basel, Switzerland  
Proteinase K  Carl Roth, Karlsruhe, Germany  
Pyruvate (PYR)  Sigma-Aldrich, St. Louis, U.S.A.  
Sodium bicarbonate (NaHCO3)  PanReac AppliChem, Gatersleben, Germany  
Sodium carbonate anhydrous (Na2CO3)  Carl Roth, Karlsruhe, Germany  
Sodium chloride (NaCl)  Carl Roth, Karlsruhe, Germany  
Sodium deoxycholate  Sigma-Aldrich, St. Louis, U.S.A.  
Sodium dodecyl sulfate (SDS) pellet  SERVA, Heidelberg, Germany  
Sodium hydroxide  Carl Roth, Karlsruhe, Germany  
Sulfosalicylic acid  Sigma-Aldrich, St. Louis, U.S.A.  
Tributylamine  Sigma-Aldrich, St. Louis, U.S.A.  
Tris base  Carl Roth, Karlsruhe, Germany  
Triton X-100  Carl Roth, Karlsruhe, Germany  
Trypton  Carl Roth, Karlsruhe, Germany  
Tween 20  Carl Roth, Karlsruhe, Germany  
Urea  Sigma-Aldrich, St. Louis, U.S.A.  
Yeast extract  Sigma-Aldrich, St. Louis, U.S.A.  
 
Reagents  
Name  
 
Company  
40% acrylamide and  
bis-acrylamide solution  
Bio-Rad, Hercules, U.S.A.  
Braford Assay Bio-Rad, Hercules, U.S.A. 
DNase I, RNase free  Thermo Fisher Scientific, Waltham, U.S.A.  
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EcoRI restriction enzyme  Thermo Fisher Scientific, Waltham, U.S.A.  
GeneRuler 1 kb DNA Ladder  Thermo Fisher Scientific, Waltham, U.S.A  
GeneRuler 100 bp DNA Ladder  Thermo Fisher Scientific, Waltham, U.S.A  
Latate dehydrogenase (LDH)  Sigma-Aldrich, St. Louis, U.S.A.  
Lowry assay  Bio-Rad, Hercules, U.S.A.  
MyTaq HS red mix  Bioline, London, UK  
PageRuler prestained protein ladder  New England BioLabs, Ipswich, U.S.A.  
Phusion PCR  New England BioLabs, Ipswich, U.S.A.  
Q5® High-Fidelity DNA polymerase  New England BioLabs, Ipswich, U.S.A.  
RNase inhibitor  Roche, Basel, Switzerland  
S.O.C. medium  New England BioLabs, Ipswich, U.S.A.  
SensiFAST™ SYBR®  Bioline, London, UK  
SuperSignal™ West Pico  
chemiluminescent substrate  
Thermo Fisher Scientific, Waltham, U.S.A.  
T4 ligase  
New England BioLabs, Ipswich, U.S.A.  
Trizol reagent  Thermo Fisher Scientific, Waltham, U.S.A.  
 
Kits  
Name  
 
 
Company  
GeneJET plasmid miniprep kit  Thermo Fisher Scientific, Waltham, U.S.A.  
GenElute(TM) gel extraction kit  Sigma-Aldrich, St. Louis, U.S.A.  
Glucose colorimetric kit  Cayman, Ellsworth, U.S.A.  
HiSpeed plasmid midi kit  Qiagen, Hilden, Germany  
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Maxima first strand cDNA synthesis kit for  
RT-qPCR  
Thermo Fisher Scientific, Waltham, U.S.A.  
NEB 5-α competent E.coli  New England BioLabs, Ipswich, U.S.A.  
Topo-TA Zero blunt cloning kit dual promotor  Invitrogen/Thermo Fisher Scientific, 
Waltham, U.S.A.  
 
Machines and Devices  
Name  
 
 
 Company 
Autoclave  Systec, Linden, Germany  
Biochrom 30+ cation exchange 
chromatography  
 Biochrom, Cambridge, UK  
BD FACS Verse Flow cytometer BD Biosciences, USA 
Blotting semidry system  PeqLab, Erlangen, Germany  
C1000 Touch Thermo Cycler  Bio-Rad,Hercules, U.S.A.  
Centrifuge  Heraeus, Hanau, Germany  
CFX Connect Real Time System  Bio-Rad, Hercules, U.S.A.  
Electrophoresis chamber  Bio-Rad, Hercules, U.S.A.  
FemtoJet micro-injector  Eppendorf, Hamburg, Germany  
Fluorescence microscope  Leica microsystems, Germany 
Fusion-SL Advance 4.2 MP  Peqlab, Erlangen, Germany  
Herathermo incubator  Thermo Fisher Scientific, Waltham, 
U.S.A.  
Microloader 20 μL  Eppendorf, Hamburg, Germany  
Microscope  Leica microsystems, Germany  
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Microwave  Sharp, Osaka, Japan  
NanoDrop LiTe spectrophotometer  Thermo Fisher Scientific, Waltham, 
U.S.A.  
Beckman Coulter AU400  Beckman Coulter, Brea, U.S.A.  
pH-Meter  WTW, Weilheim , Germany  
SDS PAGE electrophoresis system  Bio-Rad, Hercules, U.S.A.  
Sonicator  Branson, Dietzenbach, Germany  
SpectraMax Plus 384  Molecular Devices, Sunnyvale, U.S.A.  
Ultracentrifuge Typ Optima TLX  Beckman Coulter, Brea, U.S.A.  
UV-Handlamp VL-4.LC  Vilber, Eberhardzell, Germany  
UV-Transilluminator CN-TFX  Vilber, Eberhardzell, Germany  
Weighing machine PH204L  Mettler Toledo, Greifensee, Switzerland  
Weighing machine XP56  Mettler Toledo, Greifensee, Switzerland  
  
Disposables  
Name  
 
 Company  
PVDF membrane  Neolab, Heidelberg, Germany  
10 cm dish  Sarstedt, Nümbrecht,Germany  
Hard-Shell® 96-well PCR Plates, thin wall  Bio-Rad, Hercules, U.S.A  
Microseal® 'B' PCR plate sealing film  Bio-Rad, Hercules, U.S.A  
PCR tube (0.2 ml)  Sarstedt, Nümbrecht,Germany  
Thin wall capillary, 1.0 mm  World Precision Instruments, Berlin, 
Germany  
Transwell inserts 0.4µm 6-well Sarstedt AG, Germany 
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Transwell inserts 5µm 24 well Corning Incorporated, U.S.A. 
Primer Sequences  
Name Sequence 
18s Forward GTAACCCGTTGAACCCCATT 
18s Reverse CCATCCAATCGGTAGTAGCG 
 
ADPGK exon-2 Forward GCTTCTTCCAGATCATTCCTTGA 
ADPGK exon-2 Reverse TTCAGGTTTCAGACCTACTTCCT 
ADPGK CRISPR/Cas9  guide RNA GTCAATGCATGTGTTGATGTGG 
Arginase-1 Forward ACTTAAAGAACAAGAGTGTGATGTG 
Arginase-1 Reverse GCATCCACCCAGATGACTCC 
Hexokinase-2 Forward CAAAGTGACAGTGGGTGTGG 
Hexokinase-2 Reverse GCCAGGTCCTTCACTGTCTC 
Il-8 Forward GAATGGGTTTGCTAGAATGTGATA 
Il-8 Reverse CAGACTAGGGTTGCCAGATTTAAC 
iNOS Forward GTCCCGAAGTTCTCAAGGCA 
iNOS Reverse CTGTGTCACTGGACTGGAGG 
c-Myc proto oncogene Forward AAAGGCCCCCAAGGTAGTTA 
c-Myc proto oncogene Reverse GCACAAGAGTTCCGTAGCTG 
Translocated MYC Forward CACTTTGCACTGGAACTTACAACA 
Translocated MYC Reverse TCACCATGTCTCCTCCCAGCA 
XBP-1 unspliced Forward CCTTGTAGTTGAGAACCAGGAG   
XBP-1 unspliced Reverse GGTCCAAGTTGTCCAGAATGC 
XBP-1 spliced Forward GGTCTGCTGAGTCCGCAGCAGG   
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XBP-1 spliced Reverse GGGCTTGGTATATATGTGG 
Antibodies  
Name Company 
CD20-PE BD Biosciences, U.S.A. 
CD138-PE BD Biosciences, U.S.A. 
β-Actin Santa Cruz, U.S.A. 
ADPGK Sigma Aldrich, U.S.A. 
AnnexinV-FITC BD Biosciences, U.S.A. 
Calreticulin Abcam, Cambridge, UK 
GFAT-2 Santa Cruz, U.S.A. 
IP3-receptor Abcam, Cambridge, UK 
IRE-1 Abcam, Cambridge, UK 
MYC proto-oncogene Abcam, Cambridge, UK 
PDI Cell Signalling Technologies, U.S.A. 
Secondary, chicken anti-rabbit Abcam, Cambridge, UK 
Secondary, chicken anti-mouse Abcam, Cambridge, UK 
SRPR-β Abcam, Cambridge, UK 
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Methods 
Cell culture 
Ramos (RA-1, ATCC CRL-1596) B-lymphocytes and THP-1 (ATCC TIB-202) monocytes were 
maintained as a suspension culture in RPMI-1640 media supplemented with GlutaMax 
(Thermo Fisher Scientific), 10% fetal bovine serum (FBS) and 1% Penicillin/Streptomycin. Cell 
cultures were incubated for optimum growth at 37o C and 5% CO2 in a humidified 
atmosphere and fresh media added every 2-3 days. For generation of ADPGK knockouts, 
CRISPR/Cas9 technique was used. Guide RNA was designed targeting exon 2 in the ADPGK. 
Ramos cells were transfected with the guide RNA containing GFP-linked CRISPR/Cas9 
plasmid via Electroporation (Bio-Rad). Transfected cells were selected with the help of FACS 
into 96 well plates. Single cell clones were grown further and sequenced to analyze the 
presence of mutations in exon-2 near the PAM site of CRISPR guide RNA. ADPGK knockout 
was further confirmed by western blots with the selected clones using anti-ADPGK antibody 
and analyzing the loss of ADPGK activity by enzyme assays. Stimulation of cells was induced 
by PMA (phorbol 12-myristate 13-acetate) at 10 ng/ml for THP-1 cells and at 50 ng/ml for B-
cells. 
ADPGK knock-out 
ADPGK knock-out Ramos cells were generated using the CRISPR/Cas9 technology. Exon-2 in 
ADPGK gene was targeted, which also codes for the glucose binding site of the translated 
protein and hence its catalytic function. CRISPR/Cas9 plasmid expressed guide-RNA 
designed against exon-2 under a U6 promoter and a GFP (green fluorescent protein) under 
the CMV (cytomegalovirus) promoter. We used un-transfected and GFP-plasmid transfected 
cells as positive control for ADPGK and as transfection control (TC) respectively for 
subsequent experiments. All transfections were performed using Bio-Rad Gene Pulsar 
Electroporation system at recommended conditions for lymphocytes. Transfected cells were 
sorted using FACS (Fluorescence-activated cell sorting) for GFP into 96 well plates. Sorted 
single cells were allowed to grow in standard cell culture conditions until the visible 
formation of colonies. Clones were selected by detection of 55 kDa ADPGK band in protein 
lysates obtained from the colonies by western blots using anti-ADPGK antibody (Sigma-
Aldrich, HPA045194) and additionally by DNA sequencing. For sequencing, DNA was 
obtained from clones using DNeasy Blood and Tissue Kit (Qiagen) following the 
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manufacturer’s protocol and PCR (polymerase chain reaction) amplified using the Q5 High-
Fidelity DNA polymerase (New England Biolabs). The PCR products were sent for sequencing 
to Microsynth SEQLAB (Göttingen, Germany). Sequencing results were analyzed via BLAST 
(Basic local alignment search tool, NCBI) against ADPGK wild-type sequence. 
ADPGK localization studies 
From the previously performed studies in our lab showing ER (endoplasmic reticulum) 
presence of ADPGK, we wanted to distinguish between the smooth and rough ER 
localization of this protein. We used Endoplasmic Reticulum isolation kit (ER0100, Sigma-
Aldrich) for this purpose and isolated microsomes as per manufacturer’s guidelines. Briefly, 
the post mitochondrial fraction (PMF) obtained post disruption and differential 
centrifugation (standard protocols), and containing the microsomes, was dissolved in 20% 
OptiPrep sucrose density gradient medium and laid over a layer of 30% OptiPrep gradient 
medium (without PMF) in an ultracentrifuge tube. The layers were topped with 15% 
OptiPrep solution and the tube spun down in an ultracentrifuge at 150,000 x g for 3 hours. A 
total of 14 fractions were isolated from the gradient with a needle going by layers and 
stored in separate Eppendorf tubes. The protein concentration in the samples (1-14) was 
measured and the samples were later analysed via western blot for different rough ER 
markers, Calreticulin (Abcam, ab22683) and ADPGK. The principle of the experiment is 
depicted in Figure 2.1 and follows from the procedure described in (Alberts, 2017). 
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Figure 2.1: ADPGK localization experiment for rough and smooth ER: Cultured lymphocytes 
were homogenized and subjected to differential centrifugation to obtain microsomes. The 
microsomes were dissolved in 20% sucrose solution and ultra-centrifuged in a gradient of 
sucrose solution, with density increasing downwards. Figure represents the principle behind 
the experiment with low density smooth microsomes accumulating at upper layers of the 
sucrose gradient and high density rough microsomes preferentially sedimenting to the 
lower layers. 
Immunoblot Analysis 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE) was used for 
separating the proteins in cell lysates. The separated proteins were immunoblotted on PVDF 
(Polyvinylidene fluoride) membranes according to standard procedure and labelled with 
antibodies. Cell lysis was performed with RIPA (radioimmunoprecipitation) buffer using a 
pellet of 5 million cells suspended in the buffer and subjected to 10 x 5-second cycles of 
sonication. Supernatant containing the extracted proteins was resolved by SDS PAGE in 10% 
polyacrylamide gels. Prior to loading, protein concentration of all samples was determined 
by Lowry assay. Equal volume for all samples adjusted to 40 µg protein content was loaded 
in the gels.  Proteins were transferred to PVDF membranes, blocked in TBST (tris-buffered 
saline plus 0.1% tween-20) with 5% non-fat dry milk. Membranes were incubated overnight 
in primary antibody in blocking buffer and analyzed by HRP-conjugated secondary antibody 
next day using chemiluminescent substrate (ECL). Phusion GelDoc system was used for 
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visualization of results and quantification of band intensity was performed with ImageJ 
software (NIH, http://rsbweb.nih.gov/ij/).  
Quantitative RT PCR Analysis 
Total RNA was extracted from cells using TRIzol reagent (Thermo Fisher Scientific) using 
supplier’s protocol. Approximately 5 million cells were used per extraction. Isolated RNA 
was subjected to DNase treatment (DNase1-Recombinant, Sigma-Aldrich) to remove 
contaminating DNA. We then used 1 µg of resulting purified RNA to prepare cDNA with the 
help of Maxima cDNA synthesis kit (Thermo Scientific). For expression analysis by RT-QPCR, 
we used SensiMix SYBR Hi-ROX Kit (Bioline) with template cDNA and primer concentration 
according to the manufacturer’s protocol. All primers were previously verified for specificity 
by gel electrophoresis. PCRs were run on Bio-Rad CFX Connect RT-PCR Detection system at a 
preset melting cycle with annealing temperature specific for the primer set. For 
quantification, 18s ribosomal RNA expression was used as an endogenous reference. 
Expression data was quantified using 2−ΔΔCT method and stated as fold change in gene 
expression for each individual gene. 
Macrophage Migration Assay 
Migration assays were performed with 24-well Transwell inserts of 5 µm pore size 
purchased from Costar, Corning Incorporated, USA. THP-1 macrophages were seeded in 
Transwell inserts at 50,000 cells in 200 µl culture medium and stimulated by PMA for 24 
hours. Post stimulation, transwell inserts were placed in wells containing 5 x 105 wild-type 
and ADPGK KO Ramos cells which were stimulated for 48 hours in 500µl total culture media. 
The THP-1 macrophages were allowed to migrate for 6 hours. After the completion of 
migration, Transwell inserts were washed with PBS and the un-migrated cells present on the 
upper side of the inserts were removed with a cotton swab. The migrated cells on the lower 
side of the transwells were fixed overnight with 4% paraformaldehyde (PFA) at 4oC and then 
stained with DAPI (1:10000) (Figure 2.2). The DAPI-stained cells were imaged using 
Fluorescent microscopy (Leica) and later counted using the ImageJ software. Inserts 
incubated with media (no lymphocytes) were used as control. 
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Figure 2.2: Macrophage migration experiment: Diagram representing the setup and work 
flow of a macrophage migration experiment. 50,000 THP-1 monocytes were seeded in 5µm 
transwell inserts and stimulated with PMA (phorbol 12-myristate 13-acetate) for 24 hours. 
Transwell inserts were placed in wells containing 48-hour stimulated 5 x 105 wild-type and 
ADPGK KO Ramos cells. Migrated macrophages post 6 hours of incubation, collected after 
wiping off the non-migrated cells with a cotton swab, were labelled with DAPI and observed 
under a microscope. 
Macrophage-Ramos co-culture  
To reproduce the tumor-macrophage interaction at in-vitro scale, THP-1 monocytes were 
co-cultured with ADPGK KO or WT Ramos cells and their polarization into M1/M2 
macrophages was studied. In the setup, Ramos wild type or ADPGK KO cells were seeded on 
0.4 µm Transwell inserts at a density of 1 million cells/ml. The cells in inserts were 
stimulated with PMA and moved into wells of 6-well plate containing 24 hour PMA 
stimulated monocytes seeded at 2x105 cells/well in 2.5 ml of complete media. Cells were 
physically separated from each other, and migration was not possible due to small pore size 
of inserts, but the design of the setup permitted free sharing of media and soluble 
factors/nutrients between the cells (Figure 2.3). After 48 hours of co-culture, macrophages 
were collected and analyzed for M1/M2 markers of polarization (hexokinase, Il-8, iNOS1 and 
THP-1 macrophages 
in Transwell insert 
(5µm) 
ADPGK KO/WT cells 
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Figure 2.3: Ramos-macrophage co-culture: Diagram representing the setup and work flow of 
a Burkitt’s lymphoma-macrophage in-vitro co-culture experiment. THP-1 monocytes were 
seeded in 6-well plate and stimulated with PMA (phorbol 12-myristate 13-acetate) for 24 
hours. Transwell inserts containing stimulated lymphocytes were placed in the wells. 
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Macrophages were collected post 48 hours of incubation, and analyzed by RT-qPCR for 
expression of M1/M2 polarization markers. Well without insert served as control. 
 
Amino-acid analysis 
Ramos wild type and ADPGK KO cells were seeded at 1 million cells/ml in 6-well plates and 
stimulated with PMA for two days and seven days, at the end of which, cells were 
harvested, and media collected in separate 15-ml falcons. Media was further centrifuged at 
high speed and additionally passed through 0.35 µm filters to remove residual cells. 200µl of 
the sample was mixed with 50 µl Sulfosalicylic acid and centrifuged at maximum speed on a 
table-top centrifuge. Supernatant was collected, and amino acid analysis was performed by 
injecting the samples into a Biochrom 30+ Amino acid analyser (Biochrom ,UK) based on ion 
exchange chromatography, with resulting data expressed as µmol/litre.  
Lactate/Pyruvate measurements 
Media obtained from cells, as described in amino-acid analysis, was analyzed for lactate and 
pyruvate content. For pyruvate measurement the samples were mixed with pyruvate 
reagent 1 containing NADH, 1.5M Tris Base and 0.2 % HClO4 and added to reagent 2 
containing LDH (lactate dehydrogenase). For lactate measurement, the samples were mixed 
with NADH, 0.6M Glycine buffer and LDH. The completed samples were fed into and 
measured on a Beckman Coulter AU480 system (Beckman Coulter, USA), with final values 
obtained as mmol/litre. 
Flow cytometric analysis for differentiation markers 
Ramos wild type and ADPGK KO, stimulated (2 and 7 days) and unstimulated, cells were 
stained with CD20 and CD138 fluorochrome conjugated antibodies (BD Biosciences) 
according to the manufacturer’s protocol. Cells from each study sample were also stained 
with FITC-Annexin V and Propidium Iodide (BD Biosciences), for analysis of apoptosis. Flow 
cytometry measurements were performed on BD FACS Verse cytometer using BD FACS Suite 
application software. At least 100,000 cells were analyzed for each sample and appropriate 
gating was applied to the populations to exclude cell debris and doublets. Data generated 
from positive gating was analysed using FlowJo software (Tree Star, Ashland, OR, USA). 
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Bound antigens for each sample were expressed as Relative Fluorescence Intensity (RFI), 
which is the ratio of the Median fluorescence intensity (MFI) of cells labelled with a specific 
Ab to that of unlabelled cells.  
Glucose uptake assay 
Uptake of 2-NBDG (2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose glucose) 
glucose analog was measured flow-cytometrically using “Glucose uptake cell based assay 
kit” (Cayman chemicals, Europe) according to the manufacturer’s protocol. Briefly, 5 million 
ADPGK KO and WT cells were seeded in 6 well plates and stimulated with PMA for up to 
seven days. Analysis was performed with unstimulated, 2-day and 7-day stimulated cells. 
Cells were incubated in glucose free media for 4 hours before analysis. At the end of glucose 
free incubation, 2-NBDG was provided at recommended concentration for 10 minutes and 
uptake measured via FITC measurement on flow cytometer. Cells incubated with Apigenin 
served as negative control for the experiment. 
Enzyme kinetics 
For analysis of glycolytic enzyme activities, Ramos wild type and KO cells (unstimulated, 2 
and 7 days PMA stimulated) were lysed in Respiratory Chain Buffer (RCB). Around 15 million 
cells per sample were washed once with cold PBS (4oC) post harvesting and dissolved in 700 
µl cold RCB buffer. Samples were passed through 1 ml syringes fitted with 27G needles at 
least thirty times. Lysate was centrifuged at 300 g for 10 minutes to remove the debris and 
then at 7.5k in a table top centrifuge to get rid of mitochondrial pellet. The supernatant was 
then spun at 13k for 20 minutes to separate the Endoplasmic Reticulum pellet from the 
cytoplasmic supernatant. Supernatant, containing the glycolytic enzymes was used for 
analysis of Hexokinase and Gluocse-6-phosphate dehydrogenase enzyme activities using a 
colorimetric assay on a SpectraMax Plus 384 microplate reader (Molecular Devices) using 
SoftMax Pro Data Acquisition software in a 96-well plate. The enzyme activities were 
recorded as difference in absorbance at 340 nm to the absorbance at 400 nm and 
normalized to total protein content of the particular sample. 
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Mutational analysis of translocated MYC 
cDNA obtained from unstimulated, 2-day and 7-day PMA stimulated ADPGK KO and WT cells 
was used to obtain MYC region coding for 3’ segment of exon-1 and 5’ plus middle segment 
of exon-2 via PCR using Q5 DNA polymerase. The product was purified using agarose gel 
electrophoresis and gel elution and cloned into TOPO-TA zero blunt vector (Thermo Fisher) 
as per kit guidelines. The plasmid was transformed into NEB-5alpha competent E.coli (New 
England Biolabs) and plated for colony formation in LB-plates. 65 colonies from WT and 
ADPGK KO plate colonies were picked and directly sent for sequencing using “Ecoli NightSeq 
service” (Microsynth Seqlab). The obtained sequences were aligned with wild-type MYC and 
analyzed for mutations using Geneious software (Biomatters Ltd., New Zealand). 
Zebrafish xenograft studies 
Zebrafish lines care and breeding were done under standardized and controlled conditions. 
Zebrafish kdrl:GFP line, used for xenografting, was raised at 28°C in a dedicated Zebrafish 
facility available at our institute. Embryos obtained via in-cross matings were maintained in 
E3 Embryo medium. Twenty-three hours post fertilization, media was supplemented with 
0.2 mM 1-phenyl-2- thiourea (PTU, Sigma-Aldrich), to prevent pigmentation of larvae. For 
xenotransplantation, Ramos wild type and ADPGK KO cells were counted with a 
haemocytometer and stimulated with PMA. For injection, cells were fluorescently labelled 
by incubation with Cell Tracker CM-diI dye (C7001, Thermo Fisher) for 5 min at 37°C and 
further 15 minutes at 4-degree celsius. After the incubation, cells were washed once with 
PBS, and resuspended to a final concentration of 1.0 × 108 cell/ml in RPMI. Zebrafish larvae, 
48 hpf, were anesthetized with tricaine (0.02%, 168 mg/L, Sigma) and aligned on agarose 
moulds (1% agarose) in a lateral position. Around 200-250 CM-diI labelled cells were 
injected into the yolk sac of each zebrafish larva using glass microinjection needles (World 
Precision instruments, USA) with a FemtoJet microinjector (Eppendorf, Hamburg, Germany). 
Maximum pressure applied in the microinjector was 180 psi. Larvae were incubated at 28o C 
for 1 hour and then transferred to 34°C incubator for observing the growth of tumor cells. 
Xenografts were analyzed by fluorescence microscopy (Leica DMI 4000B, Leica 
microsystems) on the day of injection and 48 hours post injection. Larvae were transferred 
to individual wells in 96-well plates in fresh E3 Embryo medium supplemented with PTU, for 
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observation of tumor growth. At the time of microscopy, the E3 media was removed and 
larvae were embedded in freshly prepared 0.1% Agarose in embryo medium. Tricaine was 
added at a final concentration of 168 mg/L to anaesthetize the larvae. The low agarose 
concentration prevented movement of larvae during microscopy and assisted in their 
proper alignment and at the same time kept the larvae alive by keeping the fluid circulation 
intact. At the end of microscopy, larvae were resuspended in fresh E3 media. The embryo 
medium was replaced daily. Growth of xenografted cells in the larvae was assessed with the 
help of ImageJ software. 
 
 
 
                                                            
 
 
 
Figure 2.4: Zebrafish xenograft studies: kdrl:GFP larvae were grown at 28oC for 48 hours 
post fertilization and injected with 200-250 CM-diI labelled ADPGK KO/WT cells in the yolk. 
Larvae were transferred in 96-well plates post injection and kept for 1 hour at 28oC and 
imaged under a microscope, and then at 34oC for two days, at the end of which xenograft 
growth was observed and quantified. 50 larvae were injected for KO and WT conditions 
each. 
 
 
Xenograft growth 
at 34oC 
Day 0-Inject Day 2- Observe 
CM-diI labelled 
cells 
Yolk injection 
in 48 hpf 
kdrl:GFP larvae 
METHODS 
38 
 
 
Statistical analysis 
Statistical analysis for all data presented in the study was performed using GraphPad Prism 
(7.04). Welch’s t-test (unpaired) was used for significance analysis. A p value less than 0.05 
were considered significant. If not stated otherwise in the text, analyzed data is presented 
as mean ± standard deviation of at least three independent experiments.  
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RESULTS 
Preliminary studies 
ADPGK knock-out and localization studies 
ADPGK knockouts were generated in Ramos BL cells (Burkitt’s lymphoma) using 
CRISPR/Cas9 technology and analyzed via Western blots. Two knockouts were finally 
selected for further experiments based on loss of 55 kDa ADPGK band in western blot and 
additionally confirmed by sequencing (Fig. 3.1a). Sequencing confirmed the presence of 
heterozygous deletion/insertion in one clone (KO1: 316_317del and 319_320insC) and 
homozygous four base deletion in the other (KO2: 314_317del). 
Intracellular localization of ADPGK was performed using sucrose gradient centrifugation 
(Alberts, 2017). A total of 14 ER fractions (1-14 numbered) were obtained post gradient 
ultracentrifugation with 1 representing the least and 14 as the highest median density for 
the sample. Rough ER is bound to be present in the higher numbered fraction due to its high 
density and was accordingly detected in fractions 8-10 using markers such as SRPR-β (signal 
recognition particle receptor) and GFAT-2 (glutamine:fructose-6-phosphate 
aminotransferase). ADPGK was found to be present only in the fractions positive for rough 
ER markers and hence confirmed its presence in rough Endoplasmic reticulum (Fig. 3.1b). 
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Figure 3.1: ADPGK knock-out and localization studies. ADPGK knock-outs were generated 
via CRISPR/Cas9 technology targeting exon-2 of ADPGK. For localization studies, ER 
(endoplasmic reticulum) fraction was ultra-centrifuged in a sucrose density gradient and 14 
fractions isolated from the gradient were analyzed for ADPGK and ER markers. a: ADPGK 
(ADP dependent glucokinase) knock-out selection via western blot using 55 kDa band as 
reference. β-actin is the loading control. (1-12) depict 12 analyzed clones b: Result of 
sucrose gradient centrifugation for 14 fractions isolated from ER (Endoplasmic reticulum) 
with calreticulin as control.  C is positive control and K negative control for ADPGK. Numbers 
1-14 show the 14 isolated fractions with increasing order of density. 
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ADPGK expression upon B-cell activation 
B-cells stimulated with PMA are known to follow an initial course of activation and 
proliferation followed by differentiation into plasmablasts leading to Memory B-cells or 
Plasma cells (Benjamin et al., 1984; Ghamlouch et al., 2014; Ho, Subhendu, & Hsu, 1987). A 
burst of aerobic glycolysis marks the proliferative phase providing necessary energy and 
metabolites for growth. We wanted to see the expression changes of ADPGK in Ramos BL 
cells upon activation with a known protein kinase-C (PKC) based inducer of B-cell activation, 
phorbol 12-myristate 13-acetate (PMA) (Benjamin et al., 1984; Ghamlouch et al., 2014; Ho 
et al., 1987; Krappmann, Patke, Heissmeyer, & Scheidereit, 2001; Rousset et al., 1989; 
Valentine, Cotner, Gaur, Torres, & Clark, 1987).  
Ramos cells were stimulated with PMA for up to seven days and we measured ADPGK 
expression/activity at D2 and D7 representing the proliferating and differentiated cells 
respectively (Fig. 3.2a, b). The expression of ADPGK increased several folds upon stimulation 
and peaked at D2 where after it was found to decrease until D7 and became even lower 
than basal levels. ADPGK enzyme activity was on the other hand undetectable in 
unstimulated cells but displayed significant increase in kinetics at D2 before again becoming 
undetectable at D7. 
This depicted the correlation of ADPGK with proliferating cells and at the same time 
displaying its near-redundant nature in quiescent cells.   
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Figure 3.2: ADPGK activity and expression upon activation. Ramos BL (Burkitt’s lymphoma) 
cells were stimulated with PMA (phorbol-12 myristate 13-acetate) for a period of seven days 
and analyzed at D2 (two days post stimulation) and D7 (seven days post stimulation). a: 
Enzyme kinetics of ADPGK at D2, D7 and unstim. (unstimulated) states. X-axis represents 
time in seconds and y-axis is difference in absorbance between 340 nm and 400 nm. b: 
Change in ADPGK expression upon stimulation at D2, D7 and unstimulated states using RT-
qPCR. Data is representative of three individual experiments. Error bars represent standard 
deviation. 
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PMA stimulation induced differentiation is hampered in ADPGK KO cells 
Flow cytometric profiling signalled stalled differentiation and increased apoptosis in 
ADPGK KO cells 
CD20 and CD138 (Syndecan-1) are important markers for following B-cell differentiation 
(Jourdan et al., 2011; Tedder, Boyd, Freedman, Nadler, & Schlossman, 1985). Mature 
unstimulated B-cells are CD20+/CD138-. When stimulated by antigens they undergo cell 
surface changes to activated CD20+/CD138+ B-cells, and finally differentiate into CD20-
/CD138+ plasma cells or recently classified CD20-/low pre-plasmablasts (Ghamlouch et al., 
2014; Jourdan et al., 2011; Kaminski, Wei, Qian, Rosenberg, & Sanz, 2012; Tedder & Engel, 
1994). Flow cytometric analysis of CD20 on D0, D2, and D7 post stimulation showed a 
normal differentiation related expression of this molecule on WT Ramos cells. With high 
quantity of CD20 detected in the unstimulated state, the levels of this molecule were 
upregulated until D2 post PMA stimulation, and exhibited a drastic decrease on D7 
reflecting differentiation of WT cells (Fig. 3.3a, b). CD138 (Syndecan-1), undetected at D2, 
increased in expression at D7, though remaining at low levels but signifying a population 
positive for this plasma cell marker. 
ADPGK KO cells exhibited nearly equal concentration of CD20 in the unstimulated state as 
the WT cells and were stable till D2. On D7, the KO cells exhibited low CD20 expression, but 
levels were still much higher than WT cells. CD138 was slightly upregulated at D7 but overall 
levels of CD138 remained almost at half the values for WT cells, signifying a reduced 
capacity of these cells to differentiate into plasma cells (Fig. 3.3a, b). 
Another piece of information conveyed by flow cytometric analysis of ADPGK KO and WT 
cells was the FSC (forward scatter) and SSC (side scatter) data representing cell size and 
granularity, respectively (Ghamlouch et al., 2014). We found a consistent increase in FSC 
and SSC values in both cell lines (WT and KO) post stimulation, showing a large increase in 
size and increased cytoplasm:nucleus content for both types of cells (Fig. 3.3c). Increase in 
SSC usually represents a higher cytoplasm to nucleus ratio and thus points towards 
differentiated cells, however higher values of side scatter may also represent membrane 
blebs common in an apoptotic cell. SSC values gradually increased both for KO and WT cells 
till day 7 reflecting increased granularity and morphological changes related to 
differentiation. However, on D7 there was a significant increase in side scatter for KOs 
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compared to WT (Fig. 3.3c) most likely depicting higher number of apoptotic cells in the 
stimulated KOs which failed to differentiate. 
The morphological changes linked with apoptosis in KO cells were confirmed with Annexin V 
staining (Schutte, Nuydens, Geerts, & Ramaekers, 1998) where KO cells showed almost 70 
percent higher staining of the apoptotic marker compared to WT cells. The stained cells 
were additionally observed under a microscope and clearly depicted a much higher number 
of FITC stained cells in case of ADPGK KO cells (Fig. 3.3a, b, e). 
The increased apoptosis cell death in ADPGK KO cells seven days post stimulation was also 
confirmed by a novel marker of Ca2+ induced apoptosis, the IP3 receptor. Protein levels of 
IP3R increased dramatically for ADPGK KO cells seven days post stimulation (Fig. 3.4b, e). 
Though the levels were increased for wild type cells also, but the change was many folds 
lower than KO cells.  
Activation associated homotypic aggregation is lost in ADPGK KO cells 
B-cells are known to form homotypic aggregates due to crosslinking of CD-40 molecules or 
mediated by LFA-1 upon stimulation by appropriate antigen (L. H. Dang & Rock, 1991; 
Rousset et al., 1989) and the interaction supports the clonal expansion and activation of 
lymphocytes (Burger & Peled, 2009). We indeed found large aggregates of cells starting to 
form as early as 48 hours post stimulation with PMA in WT Ramos cells, which increased 
several folds in size up to D7. Very few individual free cells were present in the media. KO 
cells, on the other hand, were only able to form small collections of cells when compared to 
the aggregates observed in case of WTs, providing a visible evidence of hindered 
differentiation in these cells (Fig. 3.3f). The aggregates even seemed to dissociate around D7 
and only free individual cells were found in the culture after this point.   
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Figure 3.3: PMA stimulation induced differentiation is hampered in ADPGK KO cells. 
ADPGK (ADP dependent glucokinase) KO (knock out) and WT (wild type) cells were treated 
with 50 ng/ml PMA (phorbol-12 myristate 13-acetate) and cultured for seven days under 
standard conditions. Flow cytometric analysis was performed for cells collected at D0, D2 
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and D7 (unstimulated, 2 day stimulated, and 7 day stimulated) post stimulation. Panel a 
shows the change in Relative Fluorescence Intensity (RFI), which is the ratio of the Median 
fluorescence intensity (MFI) of cells labelled with a specific Ab to that of unlabelled cells 
over seven days, representing signal obtained from PE (CD20 and CD138) or FITC (AnnexinV) 
tagged fluorescent antibodies. b: The same data represented as histogram of D7 
(differentiation phase) fluorescence intensities for respective markers; pink line represents 
KO cells, blue WT and shaded area as unstimulated WT cells serving as control. c: Forward 
and side scatter values generated by the flow cytometry experiments on various days for 
WT and KO cells. Gating strategy for the experiments is represented in d for excluding cell 
debris and clumps from analysis with automated area selection for lymphocytes using 
FlowJo software. Percentage of gated cells used for further analysis is shown by the number 
in the box. e: Microscopic images of cells collected at D7 and displaying fluorescence for 
AnnexinV at 5x magnification. f: Homotypic aggregates observed at 5x magnification under a 
light microscope at D7 in PMA stimulated WT and KO cells. Error bars represent standard 
deviation of mean of RFI (for CD20, CD138 and AnnexinV) or FSC/SSC values obtained from 
three independent experiments. WT, KO: mean of values from two wild-type and two 
ADPGK knock-out cell lines.  y-axis for bar-graphs represents mean values of each sample 
normalized to unstimulated WT cells. x-axis in histograms shows fluorescence intensity. 
100,000 events were recorded for each flow cytometry experiment. (*=p < 0.05; 
**=p < 0.01, ***=p < 0.001, calculated using Welch’s t-test for significance) 
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ER stress-based differentiation markers are more expressed in ADPGK WT cells 
Independent of the well-known role of XBP1 (X-box binding protein 1) in ER stress, cell 
proceeding through the terminal stages of differentiation is bound to have increased 
content of the XBP1(s) transcript compared to the unspliced XBP1 mRNA (Reimold et al., 
2001; Todd et al., 2009) and thereby we wanted to analyse the levels of spliced/unspliced 
XBP1 in WT Ramos and ADPGK KO cells to decipher the activation induced differentiation 
status of these cells.  
We measured the transcript content of spliced and unspliced XBP1 in unstimulated, 2 day 
and 7-day PMA stimulated WT Ramos and ADPGK KO cells. We found the ratio of spliced to 
unspliced XBP1 to be higher in KO cells compared to WT in unstimulated state (almost two 
folds) (Fig. 3.4a), which is uncharacterized of Burkitt’s lymphoma. Previous studies have 
shown the very low or absent transcript levels of XBP-1 in Burkitt’s lymphoma patient 
biopsies, typical of an undifferentiated lymphoma (Maestre et al., 2009). This signalled 
stressed cellular machinery in ADPGK KO cells even in unstimulated state, as also observed 
with metabolic data for these cells. At day two post stimulation, we observed a decrease in 
XBP1 splicing in both WT and KO cells, which could be explained by increased proliferative, 
glycolytic phenotype in the activation phase post stimulation with PMA. Further, at seven 
days post stimulation with PMA, the trend reversed dramatically in favour of a 
differentiated state with almost six to eight-fold increase in XBP-1 spliced/unspliced level for 
ADPGK WT cells. The KO cells, though, exhibited a much lower comparative increase, with 
two folds higher spliced mRNA levels of XBP1, again signalling an incomplete differentiation 
owing to hampered metabolism in activation phase.  
The XBP1 splicing mechanism is completed by an ER resident protein IRE-1 and its levels in 
the cell could further shed light on the ER stress signalling operating in the cell (He, 2010; 
Tsuru, Imai, Saito, & Kohno, 2016). We thus measured phosphorylated IRE-1 protein levels 
in WT and ADPGK KO cells at the same stimulation points as for XBP1 mRNA levels. Western 
blot quantification seemed to strengthen our mRNA splicing data for XBP1 as the seven day 
stimulated cells had higher levels of IRE-1 than the two-day activated and unstimulated 
state for all cells (Fig. 3.4b, c). We were however not able to discriminate between the IRE-1 
levels for ADPGK WT and KO cells based on the protein blots.  
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Immunoglobulins, secreted by differentiated B-cells or antibody secreting cells (ASCs), are 
rich in disulphide bonds, whose formation in the endoplasmic reticulum (ER) is catalysed by 
protein disulphide isomerase (PDI) (Lilie, McLaughlin, Freedman, & Buchner, 1994). With 
several studies pointing to a correlation between the levels of PDI and the differentiated 
state of a cell (Bertolotti et al., 2010; Miyaishi et al., 1998; Paver, Freedman, & Parkhouse, 
1989), we quantified the protein content of PDI in WT and ADPGK KO unstimulated, D2 and 
D7 cells. The protein blots revealed a gradual increase in PDI levels in all cell lines upon 
activation, with levels increasing up to four-folds at D7 for WT cells (Fig. 3.4b, d). At all the 
measured time points, PDI protein levels in WT cells remained significantly higher than 
ADPGK KO cells. Overall, PDI known to act as an important mediator of protein folding for 
secreted proteins such as Ig’s and a regulator of ER stress via its chaperone activity, was 
thus found in accordance with the increased differentiation status of WT cells. 
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Figure 3.4: ER stress-based differentiation markers are more expressed in ADPGK WT cells. 
ADPGK KO and WT cells, treated with PMA and cultured for seven days under standard 
conditions were analyzed via western blot and RT-qPCR at D0, D2 and D7 post stimulation. 
a: results of RT-qPCR performed for detecting ratio of spliced:unspliced XBP1 transcript in 
KO and WT cells at different conditions. y-axis represents fold change in expression of all 
samples normalized to unstimulated WT cells. b: Western blots for WT and KO cells at D0, 2 
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and 7 with beta-Actin as loading control. c-f: quantification of band intensities using ImageJ 
software. All graphs are representative of three independent experiments. WT, KO: mean of 
values from two wild-type and two ADPGK knock-out cell lines. For western blots, TC is 
transfection control and the two knock-out lines as KO-1 and KO-2. y-axis in all graphs 
represents respective raw values normalized to unstimulated WT cells. Error bars represent 
standard deviation of mean for three individual experiments (*=p < 0.05; **=p < 0.01, ***=p 
< 0.001, calculated using Welch’s t-test for significance) 
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ADPGK KO B-cells are metabolically toxified  
ADPGK KO cells display reduced glycolysis in initial phases of stimulation driven 
differentiation 
We measured cytosolic enzyme activities of Hexokinase-2 (HK2) and Glucose 6-phosphate 
dehydrogenase (G6PDH) (Jiang, Du, & Wu, 2014) in WT and KO Ramos cells 48 hours and 
seven days post stimulation with PMA. WT cells stimulated with PMA showed significantly 
increased, 2.5-3 folds, glycolytic enzyme activities (Hexokinase-2 and G6PDH) whereas the 
ADPGK KO cells displayed a significantly reduced activation-based increase in glycolytic 
enzyme activities compared to WT cells post two days (Fig. 3.5a, d). At seven days, the 
activity values dropped to almost 20 percent of the unstimulated state activities in both cell 
type but with WT cells displaying a higher residual activity than KOs. Gene expression values 
measured via RT-QPCR for Hexokinase-2 followed the same pattern as enzymatic activities 
and suggested a stably reduced glycolytic phenotype of KO cells (Fig. 3.5b).  
ADPGK KO cells are less ‘glucoholic’ than the wild type Ramos cells 
Detection of fluorescently labelled glucose is a common non-invasive method of detecting 
aggressively growing tumors using PET-CT scan. The amount of glucose uptake by most 
cancers being much higher than the normal body cells, the glucose uptake rate correlates 
well with the aggressiveness of a growing tumor (Zou, Wang, & Shen, 2005). The same holds 
true also for rapidly proliferating cells such as activated lymphoblasts. We thus detected 
NBD-glucose in four hour-PMA stimulated WT and KO Ramos cells to adjudge their 
malignant potential and activation phenotype. Post stimulation for 48 hours and seven days, 
NBD glucose was provided to the cells and its accumulation in cells was measured via flow 
cytometry. Glucose was provided for 10 minutes duration to the cells to detect the small 
changes in rapid glucose uptake. As shown in Fig. 3.5c, in the 48 hour stimulated cells, we 
observed an increased uptake in all cells with respect to unstimulated cells but wild-type 
cells exhibiting significantly higher amounts of glucose compared to KO’s. At D7, we 
observed no significant difference in glucose uptake between wild type and KO, however 
there was a noteworthy reduction in uptake rate compared to unstimulated state in all cells. 
The results, further confirming the metabolic changes seen through enzymatic 
measurements, showed that the ADPGK KO cells were not progressing to a fully activated 
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state and were not able to upregulate glucose metabolism in the times of increased energy 
demands. 
 
 
 
Figure 3.5: ADPGK KO B-cells are metabolically toxified. ADPGK KO and WT cells were 
analyzed for aerobic glycolysis upon stimulation with PMA by measurement of enzyme 
activities a, d of Hexokinase and G6PDH (Glucose 6-phophate dehydrogenase) 
spectrophotometrically; RT-qPCR for hexokinase-2 b for gene expression, and accumulated 
FITC-NBD-glucose (2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl) Amino)-2-Deoxyglucose) c via 
flow cytometry for glucose uptake. All graphs are representative of three independent 
experiments. WT, KO: mean of values from two wild-type and two ADPGK knock-out cell 
lines. y-axis in all graphs represents respective raw values normalized to unstimulated WT 
cells. Error bars represent standard deviation of mean (*=p < 0.05; **=p < 0.01, ***=p < 
0.001, calculated using Welch’s t-test for significance) 
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Amino-acid uptake and metabolite secretion is remnant of activation driven metabolism 
in ADPGK KO cells 
Amino acids form the building blocks of proteins, lipids, nucleotides, and participate in 
almost all major energy generating reactions in the cell. Importance of several amino acids 
like glutamine and serine is further highlighted in times of stress and high proliferation 
(Mattaini, Sullivan, & Vander Heiden, 2016; Tsun & Possemato, 2015). After detection of low 
glycolytic profile of ADPGK KO cells, we thus next wanted to investigate the amino acid 
uptake rate of these cells as replenishment for hampered glucose processing.  
The results, as shown in Figures 3.6a, b depict significantly higher consumption of serine and 
glutamine by WT Ramos cells, compared to ADPGK KOs, at 2 days post PMA stimulation. 
Noteworthy was the higher increase in consumption of glutamine in stimulated state 
compared to unstimulated state (ratio, two days stimulated : unstimulated) in ADPGK KO 
cells. This could be explained by the compensatory use of glutamine in response to reduced 
glucose uptake and metabolism by these cells. However, taken as a quantitative uptake 
value, glutamine uptake levels for KO cells remained below the corresponding values for WT 
cells (1.48:1 for WT:KO). High dependence on glutamine as metabolite was further reflected 
by dramatic increase in free NH3 (ammonia) levels in media of ADPGK KO cells in 
unstimulated and stimulated states, which reflected clearly the consumption of glutamine 
(Fig. 3.6c). Ornithine, which is originally not present in media formulation used for these 
cells, and was probably a by-product of glutamine metabolism, was also detected at values 
correlating with NH3 levels and fortifies the theory of glutamine dependent energy 
generation and biosynthesis by ADPGK KO cells. 
Measurement of accumulated lactate and pyruvate levels in culture media of growing cells 
provides an estimate about the aerobic glycolysis where higher levels of lactate:pyruvate 
correspond to a more aerobic glycolytic phenotype and is a common occurrence in 
aggressively growing tumors (J. Xie et al., 2014; D. Q. Yang et al., 2016). To this end, we 
measured the lactate and pyruvate content in culture media obtained from 2 day and seven 
day stimulated cells. The levels of lactate:pyruvate rose in all cells at 2 days post stimulation 
by at least two folds, signifying actively proliferating cells (Fig. 3.6c). However, the 
comparative data again hinted towards a much-reduced aerobic glycolysis occurring in 
ADPGK KO cells with the levels of lactate:pyruvate in 2 day stimulated cells almost half of 
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that in WT Ramos cells (Fig. 3.6c). At seven days post stimulation, lactate:pyruvate values 
dropped for all cells signifying again the resting differentiated phase but as seen with other 
glycolytic data, WT Ramos cells still exhibited higher values of lactate secretion than their 
KO counterparts. 
 
Figure 3.6: ADPGK KO B-cells are metabolically toxified. ADPGK KO and WT cells were 
analyzed for aerobic glycolysis upon stimulation with PMA by measurement of amino-acids 
and metabolites in culture media at D2 and D7 post stimulation. a, b: Serine and Glutamine 
consumption in WT and KO cells at D2, D7 normalized to their respective unstimulated 
values. c: secreted metabolites in culture media at D2, D7; lactate:pyruvate levels for 
estimation of Warburg phenotype and Ornithine, NH3 values for glutamine metabolism, 
normalized to respective unstimulated conditions. All graphs are representative of three 
independent experiments. WT, KO: mean of values from two wild-type and two ADPGK 
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knock-out cell lines. y-axis in all graphs, represents respective raw values normalized to their 
unstimulated counterparts. Error bars represent standard deviation of mean (*=p < 0.05; 
**=p < 0.01, ***=p < 0.001, calculated using Welch’s t-test for significance) 
 
c-MYC expression and mutational status are dependent on glucose metabolism 
We wanted to assess the effect of PMA stimulation on expression of c-MYC transcript (both 
wild type and translocated). cDNA primers used in the study were designed to obtain 3’ 
region of exon 1 and 5’ plus middle section of exon 2, which is also the coding sequence of 
c-Myc protein. Analysis of this coding region would provide a direct cue to action of c-Myc 
as a transcriptional regulator.  
ADPGK KO cells exhibit a near complete loss of c-Myc post activation 
We performed c-MYC expression analysis of two days and seven days PMA stimulated cells, 
where the RT-qPCR results showed a significant increase in c-MYC transcript levels at two 
days post activation (Fig. 3.7a), signifying metabolically active proliferating cells and the 
change was similar in ADPGK KO and WT cells. However, at day seven post stimulation, we 
observed a strong reduction in c-MYC transcript levels, to almost 30 percent of base level 
values in WT cells but, to our astonishment, to nearly 10 percent of base level in ADPGK KO 
cells.  
The results were verified by protein blots for c-Myc protein as well (Fig. 3.7b, c); however, 
we failed to detect c-Myc in unstimulated state in all samples via western blot. The reason 
for missing c-Myc protein in unstimulated cells had yet to be determined at that point and 
has been discussed below. 
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Figure 3.7: c-MYC expression is dependent on glucose metabolism. c-MYC (translocated 
and wild-type) expression in ADPGK KO and WT cells at different time points post 
stimulation was measured via RT-qPCR and protein content via western blots. a: expression 
of MYC at D0, D2 and D7 post stimulation. y-axis represents fold change normalized to 
unstimulated WT cells. b: protein blot of c-MYC and beta-Actin loading control, with 
quantification of bands in c using ImageJ software. Expression analysis and protein blots are 
representative of three individual experiments. WT, KO: mean of values from two wild-type 
and two ADPGK knock-out cell lines. Error bars show standard deviation of mean. 
(*=p < 0.05; **=p < 0.01, ***=p < 0.001, calculated using Welch’s t-test for significance) 
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Translocated and wild-type c-Myc are expressed differentially in Ramos cells  
We also wanted to know the mutational status of the transcripts being produced at 
different time points post PMA based stimulation. We thus sequenced the MYC transcripts 
and aligned the resulting sequences with known sequences of translocated c-Myc in Ramos 
and to the wild type transcript. The results depicted as per expectations, a vast number of 
mutations accumulated in MYC transcript of Ramos cells (both WT and KO) (Fig. 3.8c, d). 
Several of the mutations were conserved throughout the sequences analysed and most of 
them matching with the known mutations in translocated MYC allele of Ramos cells and 
patient biopsy samples of Burkitt’s lymphoma (Bemark & Neuberger, 2000; Cowling et al., 
2014). However, some of the conserved mutations were novel and depicted additional 
effect of hypermutation during culture of these cells, as also known from previous studies 
(Bemark & Neuberger, 2000).  Insertions and deletions of several bases were observed 
along with point mutations. To our surprise though, upon sequencing of two day and seven 
day stimulated Ramos BL cells (both WT and KO), we obtained wild type c-Myc sequence in 
almost 50 percent of cases. This finding is in first sight, in contradiction to previous studies 
which reported that only the translocated c-Myc allele is expressed in Ramos BL cells 
(Bemark & Neuberger, 2000). However, the sequences used in previous studies were only 
obtained from unstimulated cells and true to that, we obtained only translocated c-Myc 
allele from non-PMA stimulated cells. 
This result however answered the question of failure to detect c-Myc protein in the 
unstimulated state. The translocated c-Myc being highly mutated compared to wild type c-
Myc and that being the only transcript produced in unstimulated cells, the commercial 
antibody used for detection of c-Myc will most likely not be able to bind to the desired 
peptide. Further, upon stimulation, as the expression of wild type c-Myc increases in all 
cells, we were able to detect the protein in western blots. 
Translocated c-Myc is highly mutated in WT cells compared to ADPGK KO 
Having discovered the variations in c-Myc expression levels, we were interested in random 
non-conserved point mutations which had likely accumulated due to culturing and PMA 
based activation of ADPGK wild type and KO cell lines in the lab. Analysis of 65 WT and KO 
sequences revealed astonishing results where we found 38 independent mutations in WT 
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cells and just 10 mutations in KO cells (Fig. 3.8a, b). Moreover, out of the 38 point mutations 
in WT cells, 30 were found in PMA stimulated conditions (two day + seven day). More than 
2/3rd of these (21 precisely) were found in seven day stimulated cells, clearly pointing to a 
role of activation induced hypermutation in the observation. On the other hand, ADPGK KO 
cells displayed half (5/10) mutations in the stimulated state, out of which just two were in 
seven day stimulated cells (Fig. 3.8). Knowing that ‘AGC triplets’ are a hotspot for AID 
targeted mutations in activated GC B-cells (Bemark & Neuberger, 2000; Betz, Rada, Pannell, 
Milstein, & Neuberger, 1993), we analysed the location of mutations with respect to AGC (or 
GCT, reverse complement) sites. Indeed, 20/38 or almost 52 percent mutations were at AGC 
triplets (Fig. 3.8c), out of which 18 were found in sequences from stimulated Ramos cells. A 
random mutational targeting with respect to the consensus translocated MYC sequence 
would have yielded maximum 13 percent hits on AGC triplets. Also, 36/38 targets, or almost 
95 percent mutations, were at G/C sites. There was also a preference for transitions overs 
transversions with 50 percent observed mutations occurring as transitions (randomly 
expected 33 percent). Such highly specific and preferential mutational targeting is a 
characteristic of immunoglobulin hypermutation (Bemark & Neuberger, 2000; Xu-Monette 
et al., 2016) and clearly reflected a much higher degree of organized mutations in ADPGK 
WT cells compared to the KOs. 
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Figure 3.8: c-MYC mutational status is dependent on glucose metabolism. Transcripts 
obtained at D0, D2 and D7 post stimulation with PMA for ADPGK WT and KO cells were 
sequenced and aligned with wild type MYC to analyse mutations in translocated allele. a, b:  
10 x 10 dot plot for representation of observed mutations in WT and KO cells at D0, D2 and 
D7 post stimulation. Each dot corresponds to one percent and thus the percentage of 
mutations for various time points can be calculated. Total number of observed mutations 
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for each cell line are given below the plots. c: Representative figure showing the distribution 
of random mutations and their preferential targeting to AGC sites with respect to wild type 
MYC (topmost highlighted sequence). d: figure shows the vast accumulation of conserved 
mutations in translocated MYC obtained from WT and KO cells. Mutational analysis was 
performed with over sixty individual MYC transcripts obtained from WT and KO cells at 
different time points. Sequences were aligned in Geneious software and figures exported 
are depicted. 
 
ADPGK KO leads to reduced migration of macrophages to tumor 
Immune cell, especially macrophage, migration to Burkitt’s lymphoma microenvironment is 
often considered as one of the most important factors contributing to aggressiveness of the 
disease (Coussens & Werb, 2002; Liu & Cao, 2015). The macrophages which are 
chemotactically or otherwise attracted towards the tumor niche, the Tumor Associated 
Macrophages (TAMs), are more often than not, are polarized to and serve as tumor growth 
promoting, anti-inflammatory, M2 macrophages (Genard, Lucas, & Michiels, 2017). To study 
the effect of ADPGK KO on regulation of immune cell chemotaxis, the migration of THP-1 
monocyte/macrophages was studied in presence of wild type Ramos or ADPGK KO cells. The 
quantification of migrated THP cells post 6 hours of incubation showed a marked difference 
between WT and ADPGK KOs, with the latter displaying a much-reduced number of THP 
cells which underwent migration, the number of migrated cells even approaching those 
observed with the negative control (only media, no cells) (Fig. 3.9e, f). Wild type Ramos 
exhibited migration rates more than double compared to its KO counterparts, indicating a 
significant loss in chemotactic attraction capabilities of Burkitt’s lymphoma cells upon 
removal of ADPGK. 
Macrophage M1 polarization increases with KO of ADPGK 
We aimed at replicating the tumor-immune cell interaction at an in-vitro level to understand 
the phenotype bestowed upon the macrophages by lymphoma cells. PMA activated THP-1 
monocytes were co-cultured with stimulated WT Ramos or ADPGK KO cells for a period of 
48 hours, which corresponds to the activation state of B-cells signifying high proliferation 
and high glycolytic activity found in aggressively growing lymphomas. Monocyte-
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macrophages collected post co-culture with Ramos WT or KO cells displayed a greater shift 
towards the M2 polarized state when incubated with WT Ramos cells compared to KOs as 
evident by the reduced expression of glycolytic enzymes (HK), M1 marker iNOS1 (Inducible 
nitric oxide synthase) and pro-inflammatory cytokine IL8, and increased expression of M2 
marker Arg1 (Arginase 1) (Fig. 3.9a-d) (Colegio et al., 2014; Galvan-Pena & O'Neill, 2014; 
Genard et al., 2017; Varney et al., 2002). Macrophages collected from ADPGK KO cells co-
culture on the other hand displayed enhanced expression of glycolytic enzymes (HK), which 
were significantly increased compared to the cells stimulated with PMA alone and not 
incubated in a co-culture setup, depicting a shift towards high glycolytic, M1 polarized state. 
Expression of IL8, and iNOS were also upregulated in cells collected from ADPGK KO co-
culture. On the other hand, a potent M2 marker, Arg1, was much reduced in expression in 
macrophages obtained from ADPGK KO co-culture. Overall, the expression data for M1/M2 
markers clearly showed that only macrophages co-cultured with WT Ramos cells were 
increasingly polarized to a tumor-assisting M2 phenotype, as also known in case of most 
aggressive tumors.  
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Figure 3.9: In-vitro analysis of tumor aggressiveness in ADPGK KO and WT cells. a-d: PMA 
activated THP-1 monocytes were co-cultured with stimulated WT Ramos or ADPGK KO cells 
for a period of 48 hours. Monocyte-macrophages collected post co-culture with Ramos WT 
or KO cells were analyzed via RT-qPCR for expression of M1, M2 markers in form of 
Hexokinase, IL-8, iNOS (inducible nitric oxide synthase) and Arginase 1. PMA activated THP-1 
cells without a co-culture setup served as control for the experiment. e: the migration of 
THP-1 monocyte/macrophages was studied in presence of WT or ADPGK KO cells. Media 
without WT/KO cells served as control. The quantification of migrated THP-1 cells post 6 
hours of incubation is represented as actual cell numbers on y-axis. f: Microscopic images 
representing migrated THP-1 cells upon co-culture with WT and KO cells at magnification 
2.5x. WT, KO: mean of values from two wild-type and two ADPGK knock-out cell lines in all 
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bar-graphs. Error bars show standard deviation of mean. (*=p < 0.05; **=p < 0.01, ***=p < 
0.001, calculated using Welch’s t-test for significance)  
ADPGK KO affects the growth of lymphoma xenografts in Zebrafish larvae 
To monitor the development of lymphoma xenografts in zebrafish larvae over a period of 
two days, we injected PMA activated WT Ramos and ADPGK KO cells in the yolk of kdrl:GFP 
zebrafish larvae 48 hpf (hours post fertilization). Images were taken over 48 hours (D0 and 
D2) and the growth of tumor was quantified. Images taken immediately after injection (D0), 
showed a near equal distribution of WT Ramos and KO xenografted cells in zebrafish yolk. 
Post 48 hours (D2), we observed a significant increase (up to 50 percent increase than D0) in 
the size of xenografted mass in 43/50 zebrafish larvae in case of WT Ramos cells (Fig. 3.10a, 
b). Larvae injected with ADPGK KO cells showed growth of the xenografted mass only in 
16/50 injections, plus the growth was significantly hampered compared to their WT 
counterparts. In remaining injected zebrafish, the xenografted mass surprisingly shrank in 
most of the larvae (21/34) while being consistent in size in others, likely reflecting the 
inability of KO cells to grow in an external environment owing to impeded regulators of 
aerobic glycolysis.  
This, being the first study ever with establishing of Burkitt’s Lymphoma xenografts in 
zebrafish, successfully replicated our in-vitro data and strengthened the hypothesis that 
ADPGK KO Ramos cells fail to adapt into the activation phase associated with differentiation 
and due to low Warburg phenotype, undergo apoptosis, which overall makes them less 
aggressive as a xenografted tumor when compared to WT Ramos cells.  
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Figure 3.10: In-vivo analysis of tumor aggressiveness in ADPGK KO and WT cells. 
Approximately 200-250 CM-diI labelled cells (WT or KO) were injected in yolk of 48 hpf 
(hours post fertilization) kdrl:GFP zebrafish larvae. Images in a show the progression of 
xenografted cells over two days post injection (D0 – D2) in wild type (WT, TC) and ADPGK 
knock-out (KO-1, KO-2) cells. Xenograft area quantified using ImageJ for 50 injected larvae 
with WT and KO cells each and a mean calculated over three individual experiments is 
shown in b. WT, KO: mean of values from two wild-type and two ADPGK knock-out cell lines 
in all bar-graphs. Error bars show standard deviation of mean. (*=p < 0.05; **=p < 0.01, 
***=p < 0.001, calculated using Welch’s t-test for significance)  
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DISCUSSION 
In this study we aimed at analysing the effect of ADPGK mediated glucose shuttling on 
regulation of aerobic glycolysis in Ramos BL cells, reflected by their malignant and 
differentiated status upon activation. We found invariably reduced tumor aggressiveness 
upon activation, both in-vitro and in-vivo zebrafish, and a hindered activation mediated 
differentiation of ADPGK KO cells. The data was cemented by strikingly large reduction in 
MYC transcript and protein levels in KO cells and plummeted accumulation of mutations in 
the translocated MYC allele. 
Perturbation of differentiation markers in ADPGK KO and WT cells 
Markers of differentiation in form of CD20, CD138, XBP1, increase in cell size and 
granularity, and homotypic aggregation provided a clear view of well-differentiated WT cells 
and a delayed entry to differentiation of KO cells which ultimately ended with apoptosis.  
B-lymphocyte antigen, CD20, is expressed on the surface of pre-B cells and as an important 
glycosylated phosphoprotein, is expressed throughout the development of B-cells except on 
terminally differentiated cells. The precise function of this protein still not elucidated, it is 
hypothesized to play a role in regulating calcium flux through the cell via its association with 
BCR (B-cell receptor) (Walshe et al., 2008). The expression of CD20 is variable upon 
activation and depends on the amount and type of antigen provided to the cell. It is often 
found to increase during the proliferative phase after stimulation but later becomes 
low/negative upon terminal differentiation into plasma cells (Jourdan et al., 2011; Tedder & 
Engel, 1994; Valentine et al., 1987). The low but non-negative values observed for CD20 in 
WT cells proceeding towards differentiation, signified a population not characteristic of 
plasma cells but probably a plasmablast transition state as also discussed in several other 
studies (Ghamlouch et al., 2014; Jourdan et al., 2011; D. A. Kaminski et al., 2012). However, 
the ADPGK KO cells displayed a much higher percentage of population positive for this 
marker and signalled towards a stalled differentiation pathway in these cells. The higher 
residual expression of CD20 in ADPGK KO cells is important in the light of using 
chemotherapeutics such as Rituximab which bind to surface CD20 on lymphomas and 
thereby enhances the efficacy of Natural Killer (NK) cells in destroying these malignant cells 
(Rudnicka et al., 2013). 
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Likewise, CD138 (Syndecan-1), a marker highly specific for differentiated cells, was found 
upregulated several folds in WT cells compared to KOs. Though, the overall levels of CD138 
remained low and it needs to be investigated if longer PMA based stimulation in 
combination with other cytokines is needed to upregulate the expression even further. 
Again, this signified cells proceeding through a differentiation pathway but possibly till a 
plasmablast state, as seen for CD20. The protein CD138, is a transmembrane type I 
proteoglycan, glycosylated with a heparan sulphate (HS) moiety (Kharabi Masouleh et al., 
2009). The heparan sulphate domain forms the major functional part of CD138, by binding 
to several extracellular ligands responsible for cell adhesion, morphogenesis, survival, tumor 
growth, migration and even inflammation (Kharabi Masouleh et al., 2009; McCarron, Park, & 
Fooksman, 2017). Expression of CD138 has been related to several cancers such as multiple 
myeloma, where the binding of pro-survival factor APRIL promotes cancer cell survival and 
proliferation (McCarron et al., 2017). A much reduced expression of CD138 on ADPGK KO 
cells thus explains partially the greater number of apoptotic cells observed via AnnexinV 
staining and SSC (side scatter) studies, and the inability to form homotypic aggregates 
mediated by cell-cell adhesion. The marker has been recently shown to translocate to the 
nucleus, delivering growth signals and thereby promoting tumor-stromal cross talk (Stewart, 
Ramani, & Sanderson, 2015). This might explain the low levels of marker observed on cell 
surface of both wild type and KO cells at day 7, however proving its importance in 
promoting tumor aggressiveness, as observed by its increased levels in WT Ramos cells.  
XBP1, which is an important component of the unfolded protein response (UPR) and 
promotes a balance between the adaptive and apoptotic pathways in a differentiating cell 
(He, 2010), was found to be active in unstimulated KO cells, which is otherwise unknown of 
(Maestre et al., 2009), signifying an underlying stressed ER machinery in these cells. Analysis 
of differentiation state at day 7 depicted much reduced expression of XBP1(s) in KO cells 
compared to WT, signalling strongly the reduced differentiation capability of ADPGK KO 
cells. XBP-1(s) being one of the major factors upregulated upon differentiation in plasma 
cells, we were prompted to measure the levels of its regulatory enzyme, IRE-1. With IRE-1 
protein levels undoubtedly increasing at day 7 but with no obvious difference between WT 
and KO cells, the observed variations in XBP1(s) expression remain elusive. However, 
recently discovered relationship of XBP1 with MYC, acting as partners in a transcriptional 
DISCUSSION 
67 
 
complex (H. Xie et al., 2018; N. Zhao et al., 2018), demands further research in the subject 
and would provide key to the prevailing query. PDI (protein disulphide isomerase), found in 
ER lumen, catalyses the switch between thiol-disulphide in proteins and helps in the 
formation of disulphide bonds during protein folding (Oka & Bulleid, 2013). Immunoglobulin 
(Ig) formation in plasma cells or antibody secreting cells (ASCs) involves a high load of 
proteins shuttling though the ER and requiring disulphide bond formation to constitute a 
function Ig molecule (Lilie et al., 1994; Miyaishi et al., 1998; Oka & Bulleid, 2013). Though 
the overall levels of PDI were found to increase several folds at D7, starting as early as D2, in 
all cells, the WT cells showed a significantly higher content of this protein at all stages of 
activation. This depicted a marked difference in response to increased unfolded protein 
content in the ER between WT and ADPGK KO cells, with the latter hampered in their ability 
to cope up with the highly increased flux of proteins (Ig’s) associated with B-cell activation 
and differentiation.  
The pathway to terminal differentiation was clearly stalled in ADPGK KO cells, as studied via 
various markers, and ultimately pushed these cells to apoptosis as observed from SSC, 
Annexin V and the novel IP3R study.  
Metabolic catastrophe was bestowed upon ADPGK KO cells  
A reduced Warburg phenotype upon activation for ADPGK KO cells was one of the effects 
reflected by study of glycolytic enzyme activities (HK2, G6PDH) and expression (HK2), and 
pointed to a direct link between ADPGK and BL cell metabolism. The study involved 
enzymatic and expression analysis of hexokinase-2, which is the sole isoform of hexokinase 
overexpressed in cancer (Katabi, Chan, Karp, & Batist, 1999; Mathupala, Ko, & Pedersen, 
2006; Patra et al., 2013). With HK2 expression/activity in WT cells significantly higher than 
KOs at all times but most evident at D2, depicted a low glycolytic profile of ADPGK KO cells 
post stimulation in the proliferative phase. We measured G6PDH enzyme activity, as the 
protein is involved in pentose-phosphate pathway for providing NADPH to proliferating 
cells, preventing them from oxidative damage, besides initiating the generation of 
nucleotides. The role of G6PDH activity in leukemia cell lines has been recently highlighted 
(S. N. Xu, Wang, Li, & Wang, 2016) and thus the observed differences in G6PDH activity 
between ADPGK KO and WT cells point to a reduced cancer metabolism upon removal of 
ADPGK. Detection of fluorescently labelled glucose, which is a common non-invasive 
DISCUSSION 
68 
 
method of detecting aggressively growing tumors using PET-CT scan (Cox et al., 2015), 
displayed a reduced glucose uptake by ADPGK KO cells, further confirming and reflecting the 
metabolic changes seen through enzymatic measurements. Overall the glycolytic study 
showed that the ADPGK KO cells were not able to upregulate glucose metabolism in the 
times of increased energy demands during the proliferation phase. 
Amino acids form the building blocks of proteins, lipids, nucleotides, and participate in 
almost all major energy generating reactions in the cell. Importance of several amino acids 
like glutamine and serine is further highlighted in times of stress and high proliferation 
(Mattaini et al., 2016; Tsun & Possemato, 2015). Serine, a major source of one-carbon units, 
is employed for the replenishment of ATP, NAD(P)H and S-adenosyl-methionine (SAM) 
majorly by cancer cells (Newman & Maddocks, 2017) and true to that we observed 
significantly increased uptake of this non-essential amino acid in activated WT cells 
compared to KOs. Relative to unstimulated state, the increased Glutamine uptake in KO 
cells compared to WT cells could be explained by the compensatory use of glutamine in 
response to reduced glucose uptake and metabolism by these cells. High dependence on 
glutamine as metabolite was further reflected by dramatic increase in free NH3 (ammonia) 
levels in media of ADPGK KO cells in activated states, which reflected clearly the 
consumption of glutamine. Ornithine, which is originally not present in media formulation 
used for these cells, and was probably a by-product of glutamine metabolism, was also 
detected at values correlating with NH3 levels and fortified the theory of glutamine 
dependent energy generation and biosynthesis by ADPGK KO cells.  
Measurement of accumulated lactate and pyruvate levels in culture media of growing cells 
provides an estimate about the aerobic glycolysis (J. Xie et al., 2014; D. Q. Yang et al., 2016), 
with a higher lactate:pyruvate value correlating with increased aerobic glycolysis in 
increased cancer metabolism. The almost three-fold higher lactate:pyruvate levels observed 
upon stimulation at D2 (proliferative phase) in WT Ramos cells compared to KOs, further 
fortified the metabolic study, pointing to a highly diminished Warburg phenotype of ADPGK 
KO cells. 
Overall, the presented data suggests that hampered induction of Warburg effect is 
underlying the failure of ADPGK KO cells to fully proliferate and differentiate upon PMA 
activation. 
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c-MYC expression and mutational status are hampered by ADPGK KO 
We found wild type MYC expression increasing upon activation and going down upon 
differentiation to stop cellular proliferation, as also known from B-cell differentiation 
models (Cole, 1986; C. V. Dang, 1999; Habib et al., 2007; Lin, Lin, & Calame, 2000). The 
reduction of overall levels of c-Myc at day seven signified a differentiated status of these 
cells (Lin et al., 2000; Shaffer et al., 2002). The repression of c-Myc upon differentiation 
signals the cell to stop proliferating and assume an antibody secreting phenotype (Shaffer et 
al., 2002).  
Activation of B-cells triggers AID (Activation induced cytidine deaminase) mediated somatic 
hypermutation (Clark et al., 2006; Peled et al., 2008) in the IgH locus which is required for 
creating diversity in repertoire of antibodies after contact with an antigen. In case of 
Burkitt’s lymphoma, translocated MYC becomes a target of SHM and AID mediated 
mutational activity (Adams et al., 1985; Bemark & Neuberger, 2000). However, 
accumulation of mutations, besides depending on AID activity, more importantly depend on 
the transcriptional rate of the target locus with a highly transcribing locus accumulating 
proportionally higher number of mutations (Ramiro, Stavropoulos, Jankovic, & Nussenzweig, 
2003). With AID expression levels nearly the same in WT and KO cells, it is evident that a 
higher transcriptional activity of translocated MYC under the IgH promoter was responsible 
for the intriguingly large difference in accumulated mutations between WT and ADPGK KO 
cells, thereby showing the increased proliferative, activated phenotype of WT cells upon 
stimulation. With majority of the mutations observed at D2 and D7 post stimulation, it is 
obvious that activation induced hypermutation, acting though transcriptionally active WT 
cells, was responsible for the mutational status of these cells. Also, with several observed 
mutations in MYC, known to provide a growth advantage to cancer cells (P57, T58, S62, S67, 
R83, F138 etc.), by stabilizing the MYC protein (increased half-life) (Bhatia et al., 1993; 
Cowling et al., 2014; Hemann et al., 2005; Xu-Monette et al., 2016), future research could 
aim at introducing one or more of these mutations through transgenic MYC in Burkitt’s 
lymphoma cells and observing their effects on proliferation and/or differentiation status of 
cells in which the endogenous MYC has been silenced. 
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ADPGK KO cells resemble a nutrient starved condition 
With a combined overview of metabolism, differentiation and mutational status of MYC, the 
situation observed in ADPGK KO cells is not very different from a nutrient starved cell, which 
fails to garner energy for upregulation of metabolic activity and synthesis of biomolecules. 
The desired upregulation in energy metabolism lacking in KO cells, they fail to transform 
into differentiated cells and are left with less available resources to spend for accumulating 
mutations in translocated MYC. The differentiation of B-cells into plasma cell phenotype 
requiring immense energy turnover and synthesis of thousands of proteins per minute 
(Bertolotti et al., 2010; Garcia-Manteiga et al., 2011), a healthy metabolic state becomes 
essential for cells proceeding through this pathway and the non-competent ones are pushed 
to apoptosis (Lam & Bhattacharya, 2018). A metabolically functional cell, represented in our 
study by ADPGK WT cells, will have enough energy stocks to upregulate proliferation and 
synthesis of proteins necessary for differentiating into an ASC (Antibody secreting cell) and 
also for providing evolutionary advantage to its progenies through accumulation of 
mutations. Overall, the nutrient state of the cell, acting in this case via the glucose sensor 
ADPGK, seems to be the interlinking factor between the threads of metabolism, 
differentiation and mutation accumulation. 
In-vitro  and in-vivo models of reduced tumor aggressiveness in ADPGK KO cells 
The co-culture and migration system provided added information about the oncogenic and 
transformation state of WT cells with KO cells showing reduced macrophage transforming 
capability in-vitro. Heterogenous populations of B and T lymphocytes have been shown to 
affect the polarization status of myeloid cells (de Visser, Eichten, & Coussens, 2006; 
DeNardo, Andreu, & Coussens, 2010) and hence the study provided another insight into the 
development of tumor-microenvironment with the activation status of B-cells regulating the 
immune response to tumor. We observed that activated germinal-centre B-cells can 
chemotactically attract macrophages, through migration, and transform these TAMs (tumor 
associated macrophages) to M2, tumor promoting phenotype, and that removal of a crucial 
regulator of aerobic glycolysis, ADPGK, abolishes this effect. We quantified this effect by 
measuring the expression of several important M1/M2 markers such as Hexokinase, IL8, 
iNOS and Arginase-1. Hexokinase expression which goes down upon PMA stimulation of 
THP-1 cells, went further down when the cells were incubated with WT Ramos cells, 
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signifying low glycolytic, pro-tumor M2 macrophages (Galvan-Pena & O'Neill, 2014). In 
ADPGK KO cells a contrary of this, upregulation of hexokinase levels, signified M1, anti-
tumor macrophages. Interleukin-8, responsible for chemotaxis of immune cells to tumor 
and often related with anti-tumor-phenotype (Colegio et al., 2014; Varney et al., 2002), was 
found to increase upon incubation with ADPGK KO cells, signifying their reduced tumor 
aggressiveness in-vitro. iNOS and Arg1 are a set of complementary macrophage polarization 
markers, with their role depending on differential utilization of arginine. With iNOS 
metabolizing the arginine to nitric oxide (NO), a potential anti-tumor free radical, Arginase-1 
leads to production of proline, involved in wound healing and tissue growth (Colegio et al., 
2014; Galvan-Pena & O'Neill, 2014; Z. Yang & Ming, 2014). True to their roles, we found 
increased iNOS levels in ADPGK KO cells and increased Arg1 levels in WT Ramos cells, 
displaying clearly their macrophage M1 and M2 polarization potential respectively. Overall, 
the study was a novel design to study Burkitt’s lymphoma-macrophage microenvironment 
in-vitro and thereby provided a quantitative measure of reduced macrophage polarizing 
capability and tumor aggressiveness of ADPGK KO cells. 
The study, extended to in-vivo model in zebrafish, proved further the diminished tumor 
aggressiveness of ADPGK KO cells failing to grow in an otherwise natural environment for 
tumor growth.  With an undeveloped adaptive immune system until at least 4 weeks post 
fertilization (Novoa & Figueras, 2012), the zebrafish larvae provided us a perfect model to 
study the growth of aggressive cancers in a much shorter period of time and with enhanced 
imaging possibilities than other experimental animals (Avci et al., 2018). Consistent to this, 
the use of kdrl:GFP zebrafish line (Abrial et al., 2017; Jin, Beis, Mitchell, Chen, & Stainier, 
2005) enabled us to accurately monitor the growth of CM-diI tagged xenografted cells over 
a period of two days, corresponding to the activated proliferative state of Ramos BL cells. 
The KO cells showing a striking reduction in growth of xenograft, correlating with the 
metabolic and in-vitro studies, made evident the role of ADPGK as an important regulator of 
tumor growth in-vivo zebrafish yolk. The model is superior to commercially available 2D/3D-
tumor culture models by providing an alternative natural environment with interacting 
stroma and vasculature along with the possibility of studying angiogenesis and immune cell 
involvement in the growth of tumor. This has been achieved by employing transgenic 
zebrafish lines for studying neovascularization, angiogenesis and metastasis of xenografts 
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implanted at different body locations in zebrafish larvae (Chiavacci et al., 2015; Nicoli & 
Presta, 2007; Tobia, Gariano, De Sena, & Presta, 2013; C. Zhao et al., 2011). These models of 
zebrafish xenograft provide real time imaging possibilities and monitoring dynamic changes 
in vasculature and/or tumor microenvironment (C. Zhao et al., 2011). Chemotherapeutic 
could be easily administered into larval water or directly to the tumor site by microinjection, 
providing rapid responses and precise quantification of tumor regression (Fior et al., 2017; 
Wu et al., 2017). Overall, the yolk microinjection and xenograft development model provide 
a basic but depending on components involved (neovascularization, micro-environment, 
metastasis, drug targeting etc.), a diverse system for future advances in rapid tumor 
profiling and targeting.  
Outlook 
In this study we found that Burkitt’s lymphoma cells are not permanently frozen in an 
undifferentiated state of malignancy but could be induced to follow an aerobic glycolysis-
driven activation pathway, which in the end leads to its own suppression. The study, though 
lacking the precise signalling pathway involved which leads to the observed metabolic 
catastrophe upon ADPGK knock-out, proved the importance of this protein in regulating 
glucose homeostasis and thereby acting as an important mediator in B-cell activation. 
Though indirectly, we managed to relate the suppression of an important proto-oncogene, 
MYC, with the loss of ADPGK activity. We observed the effects knowing that ER biosynthesis 
is highly upregulated in B-cells upon stimulation and a missing ER glucose sensor in form of 
ADPGK, could stall the metabolism and consequently the pathway to differentiation. 
Additionally, the reduction in glucose metabolism in knock-out cells being present even at 
unstimulated state, where ADPGK activity was undetectable, prompt us to investigate the 
possible interacting partners of ADPGK, irrespective of its catalytic function.  
The development of inhibitors against ADPGK has found success as demonstrated by a 
recent study utilizing 8-bromoadenosine phosphate (Grudnik et al., 2018), however with the 
physiological role of ADPGK still not fully deciphered, drug targets against ADPGK still await 
discovery and deployment.  
DISCUSSION 
73 
 
Overall, knowing the role of ADPGK in cancer metabolism and immune cell activation, as 
demonstrated by our study, the discovery of antibodies/inhibitors against ADPGK can have 
far reaching consequences against autoimmune diseases and immunological cancers. 
 
Conclusion 
We successfully identified the role of ADPGK in regulation of aerobic glycolysis in Burkitt’s 
Lymphoma cells and showed that its knock-out leads to reduced tumor aggressiveness, as 
measured in-vitro and in-vivo Zebrafish. We found reduced MYC transcription in ADPGK 
knock-out Burkitt’s lymphoma cells and several folds reduction in accumulated random 
mutations in translocated MYC in these cells. We additionally observed a stalled pathway to 
differentiation of ADPGK knock out B-cells into plasma cells upon stimulation by mitogenic 
signals. Overall, ADPGK was found to act as a regulator of cell-differentiation and cancer 
aggressiveness in Burkitt’s lymphoma cells.  
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